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Background: Late life depression is clinically under-recognized and under treated. 
About 17% of Singapore elderly have psychiatric disorders but only 6% of them did 
seek treatment. In recent decades, the development and validation of depression 
screening tools, primary care physician education and clinical practice guidelines have 
enhanced the prospect of early identification of depression and effective treatment. 
Recent studies have shown that multidisciplinary collaborative care treatment 
programmes were efficacious in improving outcomes of depression. 
Objectives: To evaluate the effectiveness of a community-based early psychiatric 
intervention strategy (CEPIS) of routine population screening and a structured, multi-
facetted, collaborative shared care programme for primary care treatment of 
depression 
Methods: A total of 4633 community dwelling elderly (≥ 60 yrs) who regularly used 
community social services centres, were screened using 15 items Geriatric Depression 
Screening Scale. Independently, concurrent diagnoses of major depression were made 
using Structured Clinical Interview for DSM IV (SCID). Participants who were 
screened positive for depressive symptoms (GDS ≥ 5) were visited by community 
nurses with psycho-education training in the programme and persuaded to seek care 
from CEPIS network of general practitioners. Consented and eligible elderly 
participants with depressive symptoms were randomized into two treatment groups; 
either usual care (UC) or collaborative care (CC) for primary care treatment of 
depression. Assessments of depressive symptoms, physical functional ability (IADL 
and BADL) and health related quality of life (SF-12) were performed at baseline, 3 
months, 6 months and 12 months after intervention. 
 
VIII 
Results: We found that the 15 item GDS was an excellent screening tool for major 
depressive disorder among this heterogeneous population of Asian elderly community 
dwellers (sensitivity =0.96, specificity =0.95) (Study I). Differential item functioning 
analysis of GDS suggested item responses bias associated with increasing age, 
physical disorder, gender, and ethnicity, but these were likely to have only modest 
influence of overall test performance (Study II). Following nurses’ psycho-education 
for treatment of depression, treatment seeking rate was 73.8%, greatly more than the 
reported rate of spontaneous of treatment seeking of 10.3% prior to the programme 
(Study III). Multidisciplinary collaborative care of depressed elderly showed better 
treatment outcomes compared to usual care in the randomized controlled trial. 
Compared to UC participants, significantly higher number of CC elderly participants, 
reported “satisfied” with the practical support they received from physicians and 
nurses (73%, p=0.023) and “very satisfied” with the overall care and help in the 
programme (30%, p=0.022) (Study IV). Among primary care physicians who 
participated in CC arm, 60 to 80% reported greater confidence about diagnosis and 
treatment of depression after CEPIS, and that the CEPIS model was replicable and 
applicable in primary care management of depression, and favoured encouraging the 
Ministry of Health and the College of General Practitioners to support this strategy. 
(Study IV). 
Conclusions: In the CEPIS programme, a population-based strategy of active outreach 
was effective in identifying and treating more cases of depression among the elderly. 
Structured collaborative care with treatment algorithms was found to improve 
outcomes of depression and health related quality of life among community dwelling 
depressed elderly in Singapore.  
IX 
LIST OF TABLES       PAGE
  
           
 
Study I  
1. Demographic characteristics of study sample (N=4253) 54 
2. Validity parameters of 15-GDS for varying cutoffs in whole sample 55 
3. Criterion validity of GDS-15 (cutoff 4/5) as screening instrument for 
Major depressive disorder by age, gender, ethnicity, and presence of 
Chronic medical conditions (N=4253) 
 
56 
Study II  
4. Item analysis of the GDS-15 by age, gender, ethnicity, and presence of 
any chronic illness (N=4253) 
59 
5. GDS-15 items with significant differential item functioning (DIF) by 
age, gender, ethnicity, and presence of any chronic illness shown in 
MIMIC Model 
60 
6. Response rates of screening sites and GPs in CEPIS GDS screening 65 
 
Study III  
7. Socio-demographic characteristics of screened population (N = 4633) 66 
8. Prevalence of Psychiatric Morbidities, Perceived Need and treatment  
acceptance in Screened population (N = 4633) 
67 
9. Variables associated with spontaneous help seeking and with 
acceptance of treatment through the CEPIS programme among 
participants with depressive symptoms (N=370) 
68 
X 
LIST OF TABLES       PAGE 
 
Study IV  
10. Baseline characteristics by 3 different groups (n=334) 76 
11. The adjusted means in 3 different groups and least square mean score 
differences between UC, CC VS. ENP groups over 12 months from 
linear random-effects 
77 
12. Group differences in likelihood of depression response and remission 
over 12 months assessed by Generalized Estimating Equation (GEE) 
modelling 
78 
13. Results of Comparison of health service use during the 1 year follow-
up period between groups by logistic regression 
79 
14. Patients’ satisfaction 80 
15. Physicians’ Feed Back 83 
XI 
LIST OF FIGURES       PAGE 
 
Figure 1. Flow Chart for CEPIS Intervention 50 
Figure 2. Diagram of Treatment Algorithm for Major Depressive 
Disorder 
51 
Figure 3. Participation flow chart of Depression screening 64 
Figure 4. Proportion of participation of social service centres 65 





 LIST OF ABBREVIATIONS 
 
ADL: Activity of Daily Living 
 
AGECAT: Automated Geriatric Examination for Computer Assisted Taxonomy 
 
BDI: Beck Depression Inventory 
 
CC: Collaborative Care 
 
CES-D: Centre for Epidemiological Studies Depression Scale 
 
CEPIS: Community based Early Psychiatric Intervention Strategy 
 
CONSORT: Consolidated Standard of Reporting Trials 
 
DAC: Day Activity Centre 
 
DIF: Differential Item Functioning 
 
DSM-IV: Diagnostic and Statistical Manual of Mental Disorders version IV 
 
GDS: Geriatric Depression Scale 
 
GMS: Geriatric Mental State Examination 
 
GP: General Practitioner 
 
HAM-D: Hamilton Depression scale 
 
IADL: Instrumental Activity of Daily Living 
 
ICC: Intra Class Correlation 
 
IMPACT: Improving Mood-Promoting Access to Collaborative Treatment 
 
NL: Neighbourhood Link 
 
NUH: National University Hospital 
 
NUS: National University of Singapore 
 
MDD: Major Depressive Disorder 
 
mDD: Minor Depression or sub-syndromal depression 
 
MIMIC: Multiple Indicator Multiple Cause 
 
XIII 
MOH: Ministry of Health 
 
OR: Odd Ratio 
 
PEARLS: Program to Encourage Active, Rewarding Lives for Seniors 
 
PROSPECT: Prevention of Suicide in Primary care Elderly: Collaborative Trial 
 
QOL: Quality of Life 
 
RCT: Randomized Control Trial 
 
SAC: Senior Activity Centre 
 
SAS: Statistical Analysis Software
 
SCID: Structured Clinical Interview for DSM-IV 
 
SLAS: Singapore Longitudinal Aging Study 
 
SPSS: Statistical Package for Social Science 
 
UC: Usual Care 
 




















LIST OF PUBLICATIONS 
 
1. "Criterion-based validity and reliability of the Geriatric Depression Screening Scale 
(GDS-15) in a large validation sample of community-living Asian older adults" 
Journal of Aging and Mental Health, Vol 13, No. 3, May 2009, 376-382.  
(Nyunt MS, Fones C, Niti M, Ng) 
 
2. “Differential item functioning of the Geriatric Depression Scale in an Asian 
population" Journal of Affective Disorders, 108, 2008, 285-290. 
(B.F.P Broekman, S.Z. Nyunt, M. Niti, A.Z. Jin, S.M.Ko, R.Kumar, C.S.L.Fones, 
T.P. Ng) 
 
3.“Validation of a Brief Seven Items Response Bias Free Geriatric Depression Scale” 
American Journal of Geriatric Psychiatry, 2011 June; 19 (6):589-596. 
(Broekman BFP, Miti M, Nyunt SZ, Jin AZ, Ko SM) 
 
4. “Improving treatment access and primary care referrals for depression in a national 
community-based outreach program for the elderly” International Journal of 
Geriatric Psychiatry, 2009 Nov; 24(11):1267-76. 
(Nyunt MS, Ko SM, Kumar R, Fones CC, Ng TP) 
 
5. “Determinants of Mental Health Service Use in the National Mental Health Survey 
of the Elderly in Singapore” Clinical Practice and Epidemiology in Mental Health, 
Vol 5, No. 2, January 2009, (Nyunt MS, Chiam PC, Kua EH, Ng TP) 
XV 
LIST OF APPENDICES 
 
 
Appendix 1 Ma Shwe Zin Nyunt1, Aizhen Jin, Calvin Fones2, Mathew Niti1, Tze-
Pin Ng1 Journal of Aging and Mental Health, Vol 13, No. 3, May 2009, 376-382. 
 
Appendix 2 B.F.P Broekman, S.Z. Nyunt, M. Niti, A.Z. Jin, S.M.Ko, R.Kumar, 
C.S.L.Fones, T.P. Ng Journal of Affective Disorders, 108, 2008, 285-290. 
 
Appendix 3 Ma Shwe Zin Nyunt, Soo Meng Ko, Rajeev Kumar, Calvin CS Fones, 
Tze-Pin Ng International Journal of Geriatric Psychiatry (Accepted and in process E-
Pub) 
Appendix 4 Ma Shwe Zin Nyunt, Peak Chiang Chiam, Ee Heok Kua, Tze-Pin Ng 
Clinical Practice and Epidemiology in Mental Health, Vol 5, No. 2, January 2009 
 
Appendix 5 Depression screening and recruitment questionnaires 
 
Appendix 6 Patient Informed Consent 
 
Appendix 7 Beck Depression Inventory 
 
 
Appendix 8 Hamilton Depression Scale (17 items) 
 









1.1 Aging and depression 
 
 
In ageing populations, late life depression is a major public health problem and a 
major cause of suicide in the elderly worldwide. One in five older adults have a mental 
illness, and anxiety and depressive disorders are the most common disorders among 
the elderly (Jeste et al, 1999). Approximately 1% to 3% of the general elderly 
population is estimated to have major depression and an additional 8% to 16% have 
clinically significant depressive symptoms (NIH Consensus Development Conference, 
1992). There is a great variation in the reported prevalence of depression across 
epidemiological studies. Among community dwelling elderly, up to 15% have 
reported having depression, and in geriatric outpatient clinics, approximately 1 in 4 
elderly are found to have depression (Macdonald AJ 1997). Some studies have 
reported that as many as 50% of hospitalized elderly were found to have depression 
(Koenig et al 1988; Clement et al 1999).  
In Asian region, the epidemiological studies (Liu et al 1993; Woo et al 1994; Chiu E  
2004; Liu et al 1997; Lu et al 1998; Da Canhota and Piterman, 2001) based on 
community dwelling elderly Chinese (aged ≥ 60) reported the prevalence rate of 
depression ranging from12% to 35%. In all these studies, different screening 
instruments such as; Centre for Epidemiological Studies Depression (CES-D) scale, 15 
item Geriatric Depression Scale (15-GDS) , Geriatric Mental State-Automated 
Geriatric Examination for Computerized Assisted Taxonomy (GMS-AGECAT) 
(Professor John Copeland, University of Liverpool, UK) and Hospital Anxiety and 
Depression (HAD) scale were used with different cutoff point to identify the 
depressive disorders. 
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In Singapore, the first community based epidemiological study for prevalence of 
depression reported the prevalence rate of depression to be 4.6% (Kua, 1990) with the 
Geriatric Mental State Schedule and 5.7% with the AGE-CAT program (Kua, 1992) 
among random sampling of 612 elderly Chinese (aged ≥ 65). In a second study, Kua et 
al 1996 used the GMS-AGECAT and identified 16% of depressive symptoms, 6% of 
depressive disorders and overall prevalence of major depression was 5.2% (DSM III-R) 
among random sampling of 1062 elderly Chinese (aged ≥ 65). In recent study using 
15-GDS, reported that prevalence rate of depressive symptoms was 13.3% with a 
cutoff  ≥ 5 among community dwelling Chinese older adults (aged ≥ 55) (Niti et al 
2007). 
Depressive symptoms are more frequently found in persons with older age, female 
gender, more cognitive impairment, more physical disability and lower 
education/socioeconomic status. The prognosis of late life depression remains poor. 
The result of a meta-analysis study estimated that at 24 months, 33% were well, 33% 
remained depressed and 21% died (Cole et al, 1999). Elderly with depressive disorder 
showed poorer functional performance and it is comparable to or worse than other 
chronic medical illnesses such as heart and lung disease, arthritis, hypertension and 
diabetes (Gurland et al, 1988; VonKorff et al, 1992; Wells and Burman, 1991). 
 
1.2 Aetiology of late life depression 
 
 
In older adults, the underlying factors associated with depressive symptoms or 
depressive disorders include: 
 
Biological factors: Heredity is reported to contribute 16% of variance in total 
depression scores on the CES-D and 19% of psychosomatic and somatic complaints in 
2 
community samples of elderly twins (Hopkinson G, 1964). However the risk for 
depression is lower for elderly whose immediate relatives who had late onset of 
depression after age 50 (8.3%) than the risk for elderly (20.1%) whose relatives who 
had early onset of depression at younger age. A few genetic studies reported that 
genetic polymorphisms or mutations may predispose older adults to vascular 
depression (Luisi et al, 1998; Arborelius et al, 1999).  Impairments due to vascular 
depression resembles to that of frontal lobe syndromes. Magnetic resonance 
spectroscopy (MRS) imaging studies of depressed patients showed that structural 
abnormalities were found in the areas related to the cortical-striatal-pallidal-thalamus-
cortical pathway, which were involved in spontaneous performance strategies 
demanded by executive tasks (George et al, 1994). A smaller left hippocampal volume 
was also found in depressed elderly who developed dementia over time (Steffens et al, 
2002). Magnetic resonance spectroscopic studies showed that increased myoinositol-
creatinine and choline-creatinine ratios were also associated with frontal white matter 
lesions in late life depression. Depression is found to be associated with hypersecretion 
of corticotrophin releasing factor (CRF), which mediates sleep and appetite 
disturbances and causes reduction in libido and psychomotor changes (Arborelius 
1999). Increased responsiveness of adrenocorticotropic hormone (ACTH), cortisol, 
and dehydroepiandrosterone sulfate (DHEA) to CRF were found to be associated with 
aging (Yaffe et al, 1998). In community dwelling older women, DHEA was reported 
to be negatively associated with rates of depression and number of depressive 
symptoms. Elderly with dysthymic disorder were found to have lower level of total 
testosterone than that of elderly with major depressive disorder and men without 
depressive symptoms (Seidman et al, 2002). In elderly women, study showed that 
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mood improvements were associated with hormone replacement therapy (Sherwin and 
Gelfand, 1985). 
 
Psychological factors: Behavioural, psychodynamic and cognitive aberrations are 
psychological causes of late life depression. Severe or frequent adverse life events in 
the course of life are contributing factors to the development of depression. In later life, 
the elderly may perceive the realities of aging as losses. In patients with major 
depression, the negative impact of life events is perceptibly greater. For elderly, there 
are two major life events in their life such as; earlier retirement and changes in 
household composition, characterized by the  decline of conviviality between elderly 
parents and their adult  children. Retirement can bring out the negative aspects of a 
marriage, especially for women who financially depend on their husbands (Phillipson 
C, 1997). Perceived negative interpersonal events are associated with depression in 
elders, particularly in those who demonstrate a high need for approval and reassurance 
in the context of interpersonal relationships (Alexopoulos et al, 2002).  
 
Social and demographic Factors: Impaired social support is associated with 
depression and leads to poorer outcome. Loneliness is a key factor, and less socially 
engaged elderly are more prone to have problems of depression (Blazer, 2003). 
Previous studies reported that after adjusting for socio-demographic  variables 
loneliness has been linked to depression (Alpass and Neville, 2003; Heikkinen and 
Kauppinen, 2004; Cacioppo et al, 2006) and anxiety (Hansson et al, 1986), and which 
leads to increased vulnerability of elderly to physical and mental health problems 
(Hicks, 2000). Among Asian elderly, those who live alone were more likely to be 
depressed and to report poorer mental health and quality of life than those live with 
4 
spouse and partners (Dean et al, 1992; Mui, 1998; Chou and Chi, 2000; Gee, 2000; 
Iwasa et al, 2006). The studies from Korea (Han and Yoon, 2001; You and Lee, 2006) 
reported that community elderly living alone are more likely to feel a sense of 
isolation, lose their self-esteem, and finally suffer depression, which adversely affects 
their mental and physical health. Recent study from Singapore reported that loneliness 
predicts depressive symptoms and mental component score of quality of life SF-12 
and mediates the relationship between living alone, lack of a confidant, and 
psychological well-being (Lim and Ng, 2009).  
The demographic factors such as increasing age (Valvanne et al, 1996; Berghahl et al, 
2005), female gender (Wolk and Weisman, 1995),  low level of education (Jang et al, 
2002; Minicuci et al, 2002) and social support (Bruce and Hoff, 1994; Prince et al, 
1998) are consistent risk factors for depression However, many cohort studies have 
reported that these risk factors were not associated with depressive symptoms after 
adjusting for cognitive function and other covariates (Blazer, 2003; Vink et al, 2008; 
Gao et al, 2009; Schoevers et al, 2000). In addition, the association of other 
psychosocial risk factors such as bereavement or death of loved one (Schoevers et al, 
2000), traumatic life events (Beiser, 1998), negative life events and ongoing 
difficulties (Wheaton, 1999) with depression have been studied and inconsistent 
findings were reported. 
 
Spiritual and existential factors: Spirituality is defined as an individual pursuit of 
meaning outside the world of immediate experience and religiousness is defined as 
participation in a community of people who gather around common ways of 
worshiping (Corrigan et al, 2003). A large pool of studies have reported that people 
who defined themselves as religious and spiritual have less psychological distress, 
5 
more life satisfaction and greater achievement of life goals (Hill et al, 2000). The 
course of a person’s spirituality following illness was found to be better predictor of 
outcome than a measure of psychiatric morbidity, the General Health Questionnaire 
(King et al, 1994). 
Religious coping and spirituality is more likely to be used in certain demographic 
groups such as older adults, females, blacks, those less educated, economically 
deprived and those affiliated with conservative religious denominations (Koenig et al, 
1992). 
Studies have shown that religious coping is associated with improved emotional and 
physical health. Certain types of depressive symptoms such as loss of interest, feelings 
of worthlessness, withdrawal from social interactions, loss of hope, and other 
cognitive symptoms were decreased in elderly who perceived that religion is the most 
important factor for coping with their emotional problems (Braam et al, 2001; Koenig,  
1992; Koenig 1995). Chaaya et al explained that frequent religious attendance 
enhances social resources and increase the size of social networks. Older people meet 
and share their fears, hopes and expectations at religious groups. Community cohort 
study (Bagiella et al, 2005) reported that frequent religious attendance was associated 
with an increased survival. However, most Asian religions do not require participation 
in regular worship and community gatherings. Therefore, Asian studies reported the 
lower correlation of both organizational (attendance) and nonorganizational 
(importance of religion) religiosity with depression and health, except that the spiritual 
well-being showed positive relations with health (Park and Lee, 2004). 
 
General medical conditions: Medical conditions such as; viral infection, 
endocrinopathy (hypothyroidism, hyperthyroidism, hypoparathyroidism, 
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hyperparathyroidism, hypoadrenocorticism, hyperadrenocorticism, Cushing’s disease),  
malignant diseases (leukaemia, lymphoma, pancreatic cancer), cerebrovascular 
diseases (lacunar infarcts, stroke, vascular dementia), myocardial infarction and 
metabolic disorders (B12 deficiency, malnutrition) have variously been found to be 
physiologically related to depression (Alexopoulos, 2005). 
 
Medications induced depression. Depression is related to the substance intoxication 
and withdrawal or usage of medication such as; methyldopa, benzodiazepines, 
propranolol, reserpine, steroids, anti-parkinsonian drugs, β blockers, cimetidine, 
hydralazine, oestrogens, progesterone, tamoxifen, vinblastine, vincristine and  
dextropropoxyphene. 
 
1.3  Depressive symptoms and screening tools 
 
 
Depressive symptoms include two major symptoms; depressed mood and diminished 
interest or pleasure in all or almost all activities, and other symptoms such as; weight 
loss or gain (more than 5% of body weight), insomnia or hypersomnia, psychomotor 
agitation or retardation, fatigue, feelings of worthlessness or inappropriate guilt, 
reduced ability to concentrate and recurrent thoughts of death or suicide.  
 
Validated self-administered screening instruments to identify depression are available, 
including the Geriatric Depression Scale (Yesavage et al, 1983), the Centre for 
Epidemiologic Studies Depression Scale (Radloff, 1977), the Beck Depression 
Inventory ( Beck and Steer, 1987), the Zung self rated depression scale (Zung, 1965) 
and the General Health Questionnaire (Goldberg, 1978). These instruments were 
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validated in previous studies and found to have 84% sensitivities and 72% specificities 
to detect major depression (Mulrow et al, 1995). 
 
1.4 Classification and diagnosis of depressive disorders 
 
 
According to the DSM-IV, a person who suffers from major depressive disorder 
must either have a depressed mood or a loss of interest or pleasure in daily activities 
consistently for at least a two week period. This mood must represent a change from 
the person's normal mood; social, occupational, educational or other important 
functioning must also be negatively impaired by the change in mood. A depressed 
mood caused by substances (such as drugs, alcohol, medications) or which is part of a 
general medical condition is not considered to be major depressive disorder. Major 
depressive disorder cannot be diagnosed if a person has a history of manic, hypomanic, 
or mixed episodes (e.g., a bipolar disorder) or if the depressed mood is better 
accounted for by schizoaffective disorder and is not superimposed on schizophrenia, 
schizophreniform disorder, delusional disorder or psychotic disorder. Further, the 
symptoms are not better accounted for by bereavement (i.e., after the loss of a loved 
one) and the symptoms persist for longer than two months or are characterized by 
marked functional impairment, morbid preoccupation with worthlessness, suicidal 
ideation, psychotic symptoms, or psychomotor retardation (APA, 1994).  
This disorder is characterized by the presence of the majority of these symptoms:  
• Depressed mood most of the day, nearly every day, as indicated by either 
subjective report (e.g., feels sad or empty) or observation made by others (e.g., 
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appears tearful). (In children and adolescents, this may be characterized as an 
irritable mood.)  
• Markedly diminished interest or pleasure in all, or almost all, activities most 
of the day, nearly every day  
• Significant weight loss when not dieting or weight gain (e.g., a change of 
more than 5 of body weight in a month), or decrease or increase in appetite 
nearly every day.  
• Insomnia or hypersomnia nearly every day  
• Psychomotor agitation or retardation nearly every day  
• Fatigue or loss of energy nearly every day  
• Feelings of worthlessness or excessive or inappropriate guilt nearly every day  
• Diminished ability to think or concentrate, or indecisiveness, nearly every day  
• Recurrent thoughts of death (not just fear of dying), recurrent suicidal 
ideation without a specific plan, or a suicide attempt or a specific plan for 
committing suicide. 
 
 If the patient suffers one of two major symptoms and less than 5 of other symptoms 
for at least 2 weeks and does not have a history of major depression, dysthymia, 
bipolar or psychotic disorders, minor depressive disorder (Mi DD) is diagnosed. 
 
Dysthymic disorder is diagnosed if sad mood for more days than not accompanied by 




Bipolar I disorder is diagnosed in individuals who meet criteria for major depression 
and have a history of at least one manic episode or a mixed episode. 
 
Adjustment disorder with depressed mood is diagnosed for individuals who 
developed depressed mood, tearfulness or hopelessness within 3 months of the 
occurrence of a stressor. It leads to great distress or disability and subside within 6 
months of the removal of the stressor. Bereavement is not considered as a stressor for 
adjustment disorder. 
 
1.5 Impact of late life depression 
 
 
1.5.1 Depression and chronic medical illnesses 
 
It was reported that a reciprocal and dose response relationship was found between 
Depressive symptoms with chronic medical illnesses (Wong et al, 2008). The 
prevalence of depression varies across different specific medical illnesses and the 
possible reasons include attitude towards functional impairment, perceived social 
support in patients with heart failure, (Turvey et al, 2006) and extent of illness 
controllability, particularly in patients with cancer and arthritis (Felton et al, 1984; 
Penninx et al, 1996). At a world-wide level, 9.3% of diabetes patients, 10.7% with 
arthritis, 15% with angina and 18% with asthma were found to be co-morbid with 
depression. In the Singapore Longitudinal Aging Study (SLAS I, 2003),  the 
prevalence of depressive symptoms varied with different illnesses and reported as 
24.2% with stroke, 23.7% with gastric problem, 22.3% with heart failure and 22.3% 
with asthma/COPD respectively among community dwelling elderly (Niti et al, 
2007b). Depression co-morbid with two or more chronic illnesses decreased overall 
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mean health score (Moussavi et al, 2007). Some authors suggest that greater functional 
disability and self reported poor general health might be the reasons of association 
between depression and chronic medical illness (Lewinsohn et al, 1985; Nakajima et al, 
2006). However, for certain chronic diseases like stroke, thyroid disorders, diabetes, 
heart failure and rheumatoid arthritis, direct biological mechanisms may be 
responsible for pathophysiological changes in brain, immune and endocrine function, 
which in turn contributed to depression (Evans et al, 2005). The study by Niti et al, 
2007b suggested that there might be a direct psychobiological link between depression 
and heart disease, arthritis, chronic respiratory disease and gastric problems. 
 
1.5.2 Depression and acute hospitalization 
 
 
A significant positive association of depression with acute hospitalization was found 
among community dwelling elderly (Huang et al, 2000; Ng et al, 2006) and nursing 
home residents (Boockvar and Lachs, 2002) after controlling psycho social factors, 
medical comorbidity and functional disability. 
 
There are several possible explanations for an increased risk of hospitalization in 
depressed elderly. Katon, 1996 suggested that depression exacerbates disability and 
chronic diseases, which leads to increase unexplained physical symptoms and poorer 
self perceived health status and results in increased hospitalization. Another reason 
from a study by Robertson and Katona, 1993 was that the elderly with chronic medical 
illnesses may become more depressed because of long term illnesses,  and depression 
in turn worsens the medical illness due to lack of adherence of medical treatment. 
Finally, poor health and functional status of elderly may make them consult primary 
care physicians more and increase the likelihood of hospitalization. 
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 Few prospective studies have studied the impact of depressive symptoms on specific 
disease such as; chronic obstructive pulmonary disease (COPD) (Ng et al, 2007), 
myocardial infarction (Frasure-Smith, 1995), congestive heart failure (Sherwood, 2007; 
Rumsfeld, 2005) and diabetes mellitus (Ciechanowski et al, 2000). In these studies, the 
impact of depression on worsening symptom, increased symptoms burden, functional 
impairment, and, longer stay in hospital was reported. 
 
1.5.3 Depression and functional decline 
 
Several studies have shown that depression significantly increased restrictions in basic 
activity of daily living (Penninx et al, 1999; Dunlop et al, 2005). Depressive symptoms 
such as fatigue and somatic pain may directly affect social interaction, intellectual 
activity and ability to complete daily living activities and tasks (Kondo et al, 2008). 
Social inactivity caused two to three-fold higher risks for higher ADL decline in 
severely depressed elderly than non-depressed elderly (Kondo et al, 2008). 
 
Depression has a reciprocal effect on functional disability: depression adversely 
affects functional capacity and a poor functional ability also causes depression. Lenze 
et al, 2001 reviewed the literature and identified that depression could cause or 
amplify disability in two ways; firstly it caused cognitive deficits, psychomotor 
retardation and sleep disturbance and secondly it led to greater disability from other 
health conditions. Sequelae of disability such as increased negative life events, social 
activity restriction, and strained interpersonal relationships in turn may amplify 
depression. Laukkanen et al, 1993 reported a close relation between the number of 
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ADL limitations and depressive symptoms such as loss of appetite, unsatisfied with 
their life and feel no energy. 
 
1.5.4 Depression and Cognitive function 
 
There is a positive association between depressive symptoms and cognitive 
impairment (Barnes et al, 2006; Chen et al, 2008; Doniger et al, 2006). Depression 
comorbid with cognitive impairment was found in 25% of elderly aged 65 and above 
(Blazer, 1991; Koenig and Blazer, 1992) and 30% of patients with non reversible 
dementia suffered depressive syndromes (Cummings, 1987; Miglliorelli et al, 1995). 
 
Alterations in the central nervous system may cause both cognitive decline and 
depressive symptoms. More neuronal degeneration was shown in brain area in 
Alzheimer disease patients with depression than those without depression (Zubenko et 
al, 1990). In depressed patients, reduction of blood flow was shown in the frontal lobe 
and limbic system and involved serotonergic and noradrenergic pathways, which may 
present with depressive symptoms as a prodromal or early symptoms of 
neurodegenerative diseases. Brain magnetic resonance images showed abnormalities 
in white matter and subcortical regions of elderly depressed patients (Alexopoulos et 
al, 1997). Studies (Cataldo el al, 2005; Naismith et al, 2003; Butters et al, 2004) have 
reported contradictory results of the association between different cognitive domains 





1.5.5 Depression and Quality of life (QOL) 
 
Age and severity of depression are among the most consistent predictors for QOL 
among depressed elderly. After adjusting for age, severity of depression was 
consistently associated with worse QOL (McCall et al, 1999; Alexopoulos et al, 1996). 
QOL in depressed elderly showed worse decrement than those with other common 
diseases such as hypertension, arthritis, diabetes, and heart disease (Ormel, 2000; 
Wells et al, 1989). Subjective health status, subjective mood, financial status, life 
satisfaction and subjective happiness were significantly associated with QOL among 
community dwelling depressed elderly in Japan (Wada et al, 2004). Callahan et al, 
1994 suggested that decrement in QOL might be due to significantly poorer self rated 
health of depressed elderly. In addition, depression may affect the QOL of care giver 
of depressed elderly. The psychological and financial burden of caregivers worsened 
their poor QOL. The prevalence of depression among caregivers has been reported to 
be 21%, and it showed a close relationship with suicidal ideation, depressive 
symptoms (Chessick et al, 2009) and functional impairment of the depressed elderly 
(Molynenux et al, 2008). The study showed that depressed mood in caregivers 
increased their risk of cognitive decline in digit symbol test (DST; a measure of 
processing speed, attention, cognitive – motor translation, and visual scanning), 
compared to non-caregivers, This cognitive decline in turn affects the care giving of 
depressed elderly and results in non-compliance and non-adherence to depression 








1.6 Under-diagnosis and Under-treatment of late life depression 
 
 
Although the impact of depression on quality of life of depressed elderly and their 
caregivers is of grave concern, it remains largely undiagnosed and untreated. Previous 
studies have reported that few depressed elderly used specialty mental health services 
and the majority of users received care for depression in primary care. There are 
system barriers and personal barriers to the diagnosis and appropriate treatment of 
depression in primary care. Common barriers include confounding by medical co-
morbidity, patient and physician beliefs that depression is an inevitable development 
in aging, patient and family members’ stigmatization, lack of knowledge and time for 
appropriate diagnosis and assessment, and lack of social and financial support of 
elderly to seek proper treatment (Kilbourne et al, 2004; Nutting et al, 2002; Kassianos 
G, 2006; Docherty JP, 1997). 
 
1.7 Outreach services model and collaborative care management 
 
The outreach services models have been developed to overcome the system and 
personal barriers. The primary elements of outreach services models include case 
finding, assessment, referral, treatment and consultation and they provide services like 
early intervention, facilitate access to preventive health care services, provide 
evaluation services, refer individuals to community treatment or supportive services, 
and provide services designed to improve community tenure, in settings where older 
adults reside or spend a significant amount of time. 
 
The outreach services models use either the gate keeper model (non-traditional 
community referral sources) or the traditional referral sources model to identify the 
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cases effectively in the community. In gate keeper model, community service 
personnel who have frequent contact with older persons, such as meter readers and 
utility workers, are recruited to identify and refer individuals for assessment. Whereas 
in traditional referral sources model, medical providers, family members, informal 
caregivers, or other concerned persons are used to identify the cases in community 
(Van Citters and Bartels, 2004). 
 
For effectiveness in improving psychiatric symptoms and outcomes, the outreach 
services models employ a multidisciplinary team of providers to provide a 
collaborative care. The central objective of collaborative care is to deliver empirically 
supported treatment for depression using pharmacotherapy and/or brief, structured 
psychological therapy in a form acceptable to primary care patients and providers. 
Therefore, collaborative care includes psychoeducation to support treatment adherence, 
systematic monitoring of treatment adherence and outcomes, and as-needed 
consultation with psychiatrists and psychologists. More recent models employ nurses 
or nondoctoral providers as care managers/case managers to provide education, 
monitor progress, and deliver brief psychological interventions. Psychiatrists and 
psychologists provide supervision and direct clinical contact to patients with more 
severe or treatment-resistant depression (Simon G, 2008). 
 
1.8 Pharmacotherapy (antidepressant) and psychological therapy 
Pharmacotherapy 
There are four categories of antidepressants available in the market. These are 
Tricyclics, Selective Serotonin Reuptake Inhibitors (SSRIs), Monoamine oxidase 
Inhibitors (MAOIs), and atypical antidepressants. 
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Tricyclic antidepressants (TCAs) - They inhibit the reuptake of serotonin and 
catecholamines from the synaptic cleft by blocking the reuptake transporter proteins 
that reabsorb serotonin in the presynaptic neuron after release. This results in the 
prolonged presence of the neurotransmitters in the synaptic cleft where they continue 
to stimulate the postsynaptic cell. These also block histamine receptors causing 
drowsiness and also block certain calcium channels which can be disturbing due to 
calcium’s involvement in many physiological processes, such as its involvement in the 
movement of neurotransmitters in neurons. TCAs caused several side effects like dry 
mouth, blurred vision, sweating, weight gain, etc. 
 
Selective Serotonin Reuptake Inhibitors (SSRIs) – They have similar effects to the 
TCAs but only target serotonin. Drugs like Prozac block the reuptake of serotonin 
from the presynaptic neuron by blocking the transporters that move the serotonin.  
SSRIs generally cause fewer side effects than MAOIs and tricyclics because they 
specifically block only the reuptake pumps for serotonin, not for norepinephrine. 
However they still can cause nausea, diarrhoea, headaches, loss of libido, and tremors. 
 
Monoamine oxidase Inhibitors (MAOIs) – The degradation of serotonin is mediated 
through monoamine oxidases (MAOs). MAOIs block the deamination of serotonin 
and by inhibiting its degradation it increases the concentration of 5-HT available in the 
cytoplasm of the presynaptic neuron. This increase leads to increased uptake and 
storage of 5-HT in synaptic vesicles. MAOIs inhibit the breakdown of tyramine and 
can lead to high blood pressure. They are less often used because of their drug 
interaction with other drugs. 
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Atypical antidepressants such as Wellbutrin, inhibits the uptake of dopamine, some 




It is a process focused on helping depressed patients to heal and learn more 
constructive ways to deal with the problems or issues within their life. 
Psychotherapists focus on problem solving and helping the patients to achieve their 
goals through talking and discussing techniques of coping mechanisms that the 
patients may find more effective. The common types of psychological therapy which 
therapist mostly used are behaviour therapy, cognitive therapy, interpersonal therapy, 
psychodynamic therapy, family therapy and group therapy. 
 
In Behaviour therapy, the depressed elderly was asked to keep a detailed log of all of 
their activities during the day. Therapist checked the self monitoring list for the past 
week. Weekly activities were scheduled for the depressed elderly to develop new 
activities that will provide the patient with chances for positive experience. In this way, 
therapist helps the patient develop new skills and anticipates issues that may come up 
in social interactions. 
 
In cognitive therapy, the faulty thoughts and beliefs are corrected to improve the 
person’s perception of events and emotional state. Cognitive therapists work with the 
depressed person to challenge thinking errors like personalization, dichotomous 
thinking, selective abstraction and magnification-minimization. By pointing out 
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alternative ways of viewing a situation, the person’s view of life, and ultimately their 
mood will improve. 
 
Interpersonal therapy helps the depressed person identify what their emotion is and 
where it is coming from (Identification of emotion) and helps the person express their 
emotions in a healthy way. It also help person to deal with unresolved issues from past 
relationships to their present relationships. 
 
Psychodynamic therapy makes person’s self-awareness and understanding of the 
influence of the past on present behaviour. 
 
Family therapy, therapist constructed a genogram, which looks at past relationships 
and events and what impact these have on the person’s current emotional technique. 
Depression is viewed as a symptom of a problem in the larger family. Dysfunctional 
communication patterns within the family are identified and corrected. People are 
taught how to listen, ask questions and respond non-defensively. 
 
In group therapy, six to twelve participants with related problems are grouped to 
observe others in the group and receive feedback from group members. Group therapy 
has the following advantages; 
• Increased feedback- can get feedback and different perspectives from other  
• Modelling- by seeing how others handle similar problems, the patients can 
rapidly learn new coping methods to his or her behaviours. 
• Less expensive-by grouping several patients, the cost of therapist can be 
reduced. 
19 
• Improve social skills-daily interaction with other people improves the social 
skills in group therapy. 
 
1.9 Community based Early Psychiatric Intervention Strategy (CEPIS)   
 
In Singapore, the Department of Psychological Medicine, National University of 
Singapore developed a novel outreach strategy, called “Community based Early 
Psychiatric Intervention Strategy (CEPIS)” to screen and identify depression among 
community dwelling elderly and to improve the mental health service utilization and 
treatment of depressed elderly in primary care.  
 
This CEPIS model aimed to reach out to community social service centres such as care 
corner, social activity centre, day rehabilitation centres, welfare homes, nursing homes 
and participants’ homes and actively identified depression cases using the 15 items 
Geriatric Depression Scale (GDS) by trained nurses. Trained nurses provided psycho-
education to depressed elderly and their caregivers to improve professional help 
seeking. CEPIS employ the collaborative care including multidisciplinary team such as 
trained nurse depression case manager, primary care giver (general practitioners), 
psychiatrists and counsellors to provide effective referral and management of 
depression to improve outcomes and acceptance of mental health services. 
 
A depression case manager provided the necessary support to overcome barriers to 
help seeking. Structured treatment algorithm was provided to primary care physicians 
for assessment and treatment of depression. Where necessary, the primary care 
physicians referred the cases to counsellors and specialist psychiatrists.  
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We conducted the intervention (double blinded Randomized Controlled Trial) to 
compare the collaborative care and usual care for the effective management of 
depression. 
 
1.10 Hypothesis and Objectives of the current study 
 
We hypothesized that a structured, multi-facetted, collaborative shared care in CEPIS 
outreach model, is more effective than usual care for treatment of depression among 
community dwelling elderly at primary care, non psychiatric setting. 
 
To test the hypothesis, the following objectives were conducted in 4 studies; 
 
1-To validate the 15 item GDS for use as a screening tool for major depression 
in a large whole population with a heterogeneous mix of different gender, age, 
ethnic and service needs groups (Study I) 
 
2-To evaluate the item performance of the Geriatric Depression Scale (GDS-15) 
in a large whole population of community-dwelling elderly with a 
heterogeneous mix of gender, age, ethnic groups (Study II) 
 
3-To evaluate the impact of the CEPIS outreach model in improving treatment 
acceptance and the extent to which determinants of treatment-seeking were 




4-To evaluate the effectiveness of the structured, collaborative share care in the 
CEPIS outreach model for the management of depression in a primary care 








2.1 Screening and diagnosis of late life depression 
 
 
The Geriatric Depression Scale (GDS) is the most commonly used screening tool for 
depression in the elderly.  The original 30 items scale was specially designed to 
distinguish depression from dementia in geriatric population by Yesavage et al, 1998. 
It is well validated and widely accepted for use in clinical and research settings (Stiles 
and McGarrahan, 1998). Sheikh and Yesavage, 1986 developed a shorter version of 
the GDS with 15 items (GDS-15), to reduce time and fatigue spent by patients and 
physicians. Various studies have validated GDS-15 using different cut off point for 
diverse population settings.  They reported that 1GDS-15 has respectable criterion 
validity with 79% to100% of sensitivity and 67% to 80% of specificity, and was also 
usable for cognitively mixed older populations (Jackson and Baldwin, 1993; Lesher 
and Berryhill, 1994).Diagnostic and Statistical Manual of mental disorders version IV 
(DSM-IV) (APA, 1994) and the International classification of Diseases and Related 
Health Problems 10th edition (ICD-10) (WHO, 1992) were most commonly used as 
diagnostic ‘gold standard’ for depression. These two systems provide similar ways to 
define depression episode, however, they include different structure to diagnose 
depression. In ICD-10, depressive episodes are diagnosed from mild to severe disorder 
with different symptom thresholds, whereas in DSM-IV, more specific inclusion and 
exclusion criteria are provided for diagnosis. 
 
23 
Compared to ICD-10, DSM-IV provides multiple options for specifiers of the current 
clinical status, including severity, psychotic and remission specifiers and longitudinal 
course specifiers. It also offered research criteria for mixed anxiety-depressive 
disorder, which is useful since the anxiety is a common comorbid disorder with 
depression (Gruenberg et al, 2005). 
 
2.2 Criterion validity of 15-GDS  
 
The Geriatric Depression Scale (GDS) has reportedly shown good to excellent 
criterion validity as a screening instrument for Major Depressive Disorder (MDD) 
(Almeida and Almeida, 1999). In a meta-analysis (Wancata et al 2001), the GDS-15 
showed an average sensitivity of 0.805, and specificity of 0.750. These pooled 
estimates were derived from mostly small samples (40 to 700) in a variety of settings 
such as primary care clinics, geriatric outpatient clinics, nursing homes, or similar 
sheltered housing facilities. None of them have evaluated the GDS in a large whole 





2.3 Differential Item functioning (DIF) of 15 item GDS 
 
The test performance of the GDS may vary in different studies and heterogeneous 
populations because individual item in the scale may be biased by factors such as 
gender, age, ethnicity and chronic illnesses (Wancata et al., 2006). Comparisons of 
differences in depressive symptoms between population groups may be invalid if one 
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or more scale item(s) exhibit group-related response bias, or synonymously 
“differential item functioning” (DIF) (Teresi et al., 2000). DIF is present if members 
of different groups possessing the same latent depression severity do not have the 
same probability of endorsing the item(s) (Camilli and Shepard, 1994). Such group-
specific DIF’s are deemed to create item-level artefacts, which individually or 
collectively may create varying extent of test-level artefacts (Niti et al., 2007, a). DIF 
studies of depression scales were few and recent, but there was an evidence of item 
bias associated with physical disorder, age, gender and ethnicity in the Centre for 
Epidemiologic Studies Depression Scale (Grayson et al., 2000). 
 
Watson et al., 2004 reported that the screening accuracy of the GDS was poor in 
elderly above 70 years (old-old) healthy adults. According to some authors (Mui et al, 
2001), ethnicity might play an important role when investigating the accuracy of 
assessment of geriatric depression. Few authors have reported the ethnic composition 
of their sample or have only investigated the performance of the GDS in specific 
ethnic groups (Rait et al, 1999; Abas et al, 1998; Gerety et al 1994), without 
comparing the relative performance of the GDS among different ethnic groups in the 
same sample. 
 
Sscreening instruments are often culture-specific, and though well established in one 
population, should be evaluated for item bias before being used in clinical practice and 







2.4 Barriers for mental health services utilization 
 
Mental illness among older adults is highly prevalent and significantly impact on 
health, functioning, health service use and costs. Over the past 15 years, a large body 
of evidence has firmly supported the efficacy of pharmacologic and psychotherapeutic 
interventions in improving outcomes of older adults with depression (Bartels et al., 
2002). Despite this, mental illness is undertreated. It is estimated that approximately 
half of older adults with a recognized mental disorder do not receive mental health 
services (Sartorius et al., 1993; The WHO World Mental Health Survey Consortium, 
2004; Klap et al., 2003). The continuing challenge is to identify the salient factors 
determining mental health service use in a healthcare system, and to develop and 
evaluate innovative strategies to improve mental health service use and outcomes.   
 
The underuse of mental health services by older persons is attributable to both 
personal and system barriers. Using the behavioural model of health service use 
(Andersen and Newman, 1973), the personal factors which determine use of services 
include need-for-care factors (such as mental disorder, perceived health and disability), 
enabling factors which facilitate or hinder the use of mental health services, and 
predisposing factors that refer to background characteristics which may influence 
attitudes and beliefs concerning health and use of services. The system barriers include 
difficulty of access to professional psychiatrists in community setting and limited 
training of general practitioners in psychiatry. Physician’s under-diagnosis of 
depression in the elderly is attributable to the masking of depressive symptoms by 
comorbid physical illnesses, low threshold for clinical recognition, and time 
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constraints of practice (Andrews et al., 2001; Bijl and Ravell, 2000; Goldberg and 
Huxley, 1980; Kessler et al., 1999). 
 
Among the elderly, the salient barriers to access and use of professional treatment for 
mental ill-health include physical illness and frailty, isolation, costs, transportation 
difficulty, lack of knowledge of access to mental health services, negative beliefs and 
attitudes as regards the causes and nature of mental illness, stigma and lack of trust 
with professionals (Lin and Parikh, 1999; Wrigley et al., 2005; Luber et al., 2001). 
 
2.5 Outreach service programmes 
 
In recent years, a variety of outreach service models for increasing access and use of 
mental health services by older people has been described in the literature (Van Citters 
and Bartels, 2004). By removing barriers and facilitating access to mental health 
services, outreach services have the effect of providing care equitably to all in need, 
such that service use becomes determined primarily by need for care, with little or no 
significant influence by socioeconomic and other extraneous variables. However, there 
are few reports of the effect of primary care outreach programmes in improving access 
and increasing use of mental health services.   
 
STUDY IV 
2.6 Collaborative Care Model (CCM) 
 
Sufficient evidence from previous studies showed that dissemination and 
implementation of collaborative care model are effective in management of depression. 
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CCM interventions can be ranged from simple telephone interventions to encourage 
compliance with medication (Peveler et al, 1999) to complex interventions at the 
systems level. CCM at the system level include a multi-professional approach to 
patient care, activated patients, a structured patient management plan, scheduled 
patient follow-up, and enhanced inter-providers communications. CCM for depressed 
elderly, used in primary care settings, was more effective than usual general practice 
care and its feasibility and effectiveness were acceptable in United Kingdom (Chew-
Graham et al, 2007) 
 
2.7 Studies evaluating the effectiveness of outreach service programmes 
 
The effectiveness of outreach services for older adults with mental illness in non-
institutional community settings has been evaluated by randomized controlled trials, 
quasi-experimental outcome studies, controlled prospective cohort studies, 
uncontrolled prospective cohort studies, uncontrolled retrospective cohort studies and 
interventions. 
 
Studies evaluating the effectiveness of case identification models have compared 
gatekeeper model (non-traditional community referral sources) to traditional referral 
sources (medical providers, family members, informal caregivers, or other concerned 
persons) (Florio et al, 1996 and 1998). These studies reported that older adults referred 
by gate keepers were significantly more likely to have socio-economic problems and 
less likely to use the health services than those referred by traditional sources. 
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Other interventional studies of community based mental health outreach models have 
examined the impact of such services on symptoms and community tenure. 
Multidisciplinary team, formed by primary care physicians, psychiatrists, therapists, 
psychologists, nurses and social workers, were employed in these models to provide 
collaborated shared care at residential settings. The Depression Care Management 
(DCM) was provided by different care providers across different studies such as; 
primary care physicians (Llewelllyn-Jones et al, 1999), case manager (Seidel et al, 
1992), trained nurses (Waterreus et al, 1994; Blanchard et al, 1995; Rabins et al, 2000), 
caregivers and other employees of residential home (Cuijpers et al, 2001) and social 
workers (Ciechanowski et al, 2004; Kohn et al, 2002).  All these multidisciplinary 
outreach interventions conducted education, training and support in the older adult’s 
place of residence and gave feedback to residential care providers.  
 
The “Program to Encourage Active, Rewarding Lives for Seniors” (PEARLS) study 
provided DCM including problem-solving therapy (PST) with an emphasis on 
behavioural activation, consisting of eight (50 minutes) in home sessions over 19 
weeks at depressed elderly home (Ciechanowski P et al, 2004). Other interventions 
such as “Improving Mood Promoting Access to Collaborative Treatment” (IMPACT) 
program (Unutzer J et al, 2002) and “Prevention of Suicide in Primary Care Elderly: 
Collaborative Trial” (PROSPECT) (Bruce et al, 2004) delivered DCM in a clinic. 
They offered problem solving therapy in primary care (PST-PC) and care managers 
provided education and support with antidepressant medication management to the 
primary care physician, under the supervision of a psychiatrist. These studies showed 
improvement in global functioning and reduction in psychiatric symptoms with fewer 
behavioural disturbances among elderly with mental illness. 
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However, most studies have the common limitation of only identifying isolated older 
adults with mental illnesses and treating older adults with comorbid psychiatric 






3.1 Study population 
 
3.1.1 Recruitment and Inclusion/Exclusion Criteria 
 
This study formed part of a health service research that evaluated a community-based 
programme to screen and treat major depression in the elderly living in the community, 
and was ethically approved by the Domain Specific Review Board (DSRB) in 
Singapore. The study was conducted in a total of 42 social service sites which 
provided social and recreational services for the elderly (care corner social services, 
senior activities centres, neighbourhood links), 18 special needs services (social day 
care centres, rehabilitation centre), 12 sheltered/welfare home facilities and 4 nursing 
homes, all across the island state.   
 
Care corner social service centre, senior activity centres and neighbourhood links are 
located in housing precincts and provide community based services that assist the 
elderly in coping with daily demands of living in the community, enhance their quality 
of life, provide and support caregivers through information and referral, consultations 
and training, as well as provide meals, social and recreational activities, the 
supervision and maintenance of therapy programs. 
 
Social day care and rehabilitation centres are also located in the community and 
provide rehabilitative services, social and recreational activities to elderly with 
multiple needs (medical, social, and psycho-social) including those who are frail.  
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Community/sheltered homes provide assisted independent living for the ambulant 
elderly to continue their living within the community. The residents in these homes are 
physically and mentally fit and capable of taking care of their daily living activities. 
Welfare homes located in community are homes for care, reception and rehabilitation 
of destitute persons. 
 
 Nursing homes provide residential facilities and nursing care for the elderly sick and 
those suffering from physical or mental dysfunction requiring high level nursing care. 
They also provide physiotherapy and social recreational activities. 
 
In these service sites, elderly age 60 years and above who were citizens or permanent 
residents and regularly used the services in these social service agencies were invited 
to participate in the screening. Elderly contacts who had severe dementia, profound 
hearing, visual and speech impairment, and severe physical illness(es) and had 
difficulties completing the GDS were excluded from the study. 
 
3.1.2 Study design and Sample size 
 
Study I: Criterion validation of the GDS-15 
Study II: Differential Item Functioning of the GDS-15 
Study III: CEPIS Outreach model to improve acceptance of primary care treatment 
Study IV: Structured Collaborative, shared care in CEPIS outreach model Vs usual 
care and eligibility non-participant, for treatment of depression in Primary Care, non-
psychiatric setting 
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Study I, II and III were cross sectional studies and Study IV was Randomized 
Controlled Trial. Study I and II used data that were analyzed for an initial group of 
4253 participants who were recruited and screened for depression. For Study III, data 
was analyzed after final completion of depression screening with total number of 
participants 4633. From the screening, participants who were screened positive on the 
15 items GDS and satisfied eligibility criteria were invited for the randomized 
controlled trial (Study IV). This involved 274 consented depressed elderly. All studies 
in this thesis were ethically approved by the Domain Specific Review Board (DSRB) 
and conducted between 2005 and 2008 in Singapore. 
 
3.1.3 Baseline socio-demographic data collection 
 
Data for socio-demographic characteristics including age, gender, ethnicity, 
educational level, housing types, living arrangements and marital status was collected 
during face to face interview. The presence of one or more chronic medical illness in 
the past one year was recorded from participants’ self reports. The participants were 
asked to rate their mental health status as either ‘Poor’, ‘Fair’, ‘Good’, ‘Very good’ or 
‘Excellent’, whether they perceived a need for professional help with mental and 
emotional problems in the past month, and whether they had on their own sought 
treatment for mental problems in the previous 12 months.  
 
3.2 Depression Screening 
 
The Geriatric Depression Scale (GDS) (Yesavage 1988) is a 15 item questionnaire 
with a “yes/no” format. The scores range from 0 to 15; most studies reported that GDS 
scores of five or above indicates probable depression. English, Chinese and Malay 
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versions of the GDS-15 derived from forward and backward translations were 
evaluated for linguistic and semantic equivalence, and were administered by face-to-
face interviews with trained and experienced nurses in the languages and dialects 
preferred by the respondents (Appendix 5). 
 
3.2.1 Criterion validity of 15-items GDS (Study I) 
 
The external criterion measure was a diagnosis of major depressive disorder made 
from Structured Clinical Interview for DSM-IV (Diagnostic and Statistical Manual of 
Mental Disorders, Fourth Edition)-(SCID-IV). A medically-qualified researcher with 
psychiatric training, who was blinded to the results of the GDS screening, 
independently performed the structured clinical interview within two weeks after the 
GDS screening interview. 
 
The test-retest of the GDS-15 was evaluated by administering the questionnaire to the 
same respondents (N=1000) a second time about 2 weeks after the first interview.  
 
Inter rater reliability among 7 interviewers was evaluated in 30 elderly respondents of 
different age, gender and ethnicities, who were interviewed by one interviewer and 
rated independently by all interviewers. 
 
3.2.2 Differential item functioning (DIF) of 15-item GDS (Study II) 
 
The GDS-15 and Structured Clinical Interview for DSM-IV (SCID) diagnosis of 
MDD were independently administered by interviewers on 4253 non-institutionalized 
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community living elderly subjects aged 60 years and above who were users of social 
service agencies. Multiple-Indicator Multiple-Cause latent variable modelling was 
used to identify DIF. 
  3.3 CEPIS Outreach model (Study III and Study IV) 
 
The CEPIS outreach model includes the following features: (1) community-wide 
outreach through the portals of activities and services of neighbourhood social service 
centres for seniors; (2) active case detection through routine screening of depressive 
symptoms; (3) psychoeducation and individual counselling by trained nurse educators 
to accept referral for treatment (4) case manager support to facilitate visits to general 
practitioners, (5) primary care treatment of depressed patients by trained general 
practitioners in private practices in the neighbourhoods of the elderly residents, with 
case management support by nurses.  
 
3.3.1 Recruitment at community social service centres 
 
Community outreach targeted the senior clients who are registered users of 42 social 
service sites throughout Singapore which provide social and recreational services for 
the elderly (care corner social services, senior activities centres, neighbourhood links), 
18 special needs services (social day care centre, rehabilitation centre) and 12 
sheltered/welfare home facilities and 4 nursing homes.  A team of research assistant 
and trained nurses visited these social service sites and explained about the depression 




3.3.2 Depression screening 
 
Active case detection was conducted through routine screening for depression. Seniors 
were routinely screened for depressive symptoms by trained nurses using the brief 15-
item Geriatric Depression Scale (GDS) (Yesavage J, 1968), either at the centres or at 




Trained nurses performed psycho-education (both group and individuals) for 
participants with 5 or more depressive symptoms and for their caregivers to counsel 
them to accept referral for assessment and treatment by a general practitioner enrolled 
in the CEPIS programme. The educational efforts provided information about 
depression and its causes and treatment, availability of care by a general practitioner, 
and addressed commonly held negative beliefs and attitudes, in order to overcome 
stigma and distrust of professional care of mental illness. 
 
3.3.4 Referral for primary care treatment 
 
A case manager in the CEPIS provided supportive services such as help with 
transportation, making appointments, etc. to overcome physical barriers and facilitate 
seniors with depressive symptoms to make the visit to a CEPIS-registered general 




3.3.5 Acceptance of referral for treatment of depression 
 
Within a month following psycho-education and counselling, case managers for the 
participants with depressive symptoms subsequently contacted the GP and determined 
whether the participant had accepted referral for treatment.  
 
3.3.6 Primary care treatment in an integrated structured collaborative shared 
care  
 
Primary care doctors enrolled in the CEPIS programme were identified from general 
practices in close proximity to the elderly participants residing in the same localities. 
Participating GPs were provided training in primary care management of late life 
depression, and treated the patients according to a management protocol and treatment 
algorithm with support from a case manager and nurse educator, referral to a 
psychotherapist or psychiatric specialist for specialized care. 
 
3.4 Randomized Control Trial (Study IV) 
 
A Randomized, controlled, double-blind, parallel-group 6 months interventional trial 
was conducted to compare the outcomes of collaborative care treatment and usual care 
treatment. Randomisation was done by using computer-generated random numbers; 
the research assistant who recruited patients was neither involved in nor did aware of 
the procedure use to generate allocations. Allocations were kept in numbered sealed 
envelopes in each clinic, and were opened by an individual who had not recruited the 
patients.  
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Participating GPs who were referred patients with depressive symptoms were either 
only aware that they were providing care in the usual way or only aware that they were 
participating in the study to test the feasibility of a proposed structured, collaborative 
care programme of management of depression in primary care clinics. The study 
patients were informed in the consent form that the study was to ‘study ways with 
which your doctor can better help you with concerns about your emotional, mental and 
physical well-being’ 
 
3.4.1 Inclusion and Exclusion Criteria 
Inclusion criteria: 
1. Screened positive on GDS (score of 5 or more) 
2. Provide written informed consent (personally or a family relation who is a 
primary care giver) 
 
Exclusion criteria: 
1. Patients with current psychotic symptoms, serious suicidal risk, history of 
mania, or current alcohol abuse 
2. Patients with concurrent Alzheimer’s disease or vascular dementia (CDR 
>=1.0) 
3. Patients with severe functional restrictions on activities of daily living 
(fully dependent at 3 or more basic ADLs) 
4. Patients with post-stroke dementia, residual aphasia  
5. Patients who had had a psychiatric consultation or admission to hospital in 
the 3 months before the interview 
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6. Previously unrecognized patients with very high GDS score more than 11 
(which are almost certain to be major depression) and confirmed to be 
major depression from SCID. These subjects are referred to a primary care 
physician or psychiatrist for further care 
 
3.4.2 Study procedures 
 
Patients who fulfil eligibility criteria and with GDS scores ≥ 5 (positive screen for 
depression) were randomly assigned in equal numbers to either intervention group or 
the control group: 
 
Intervention Group-Collaborative Care (CC) (Figure 1) 
Results of GDS screen-positive patients were fed back by the depression case manager 
(DCM) to GPs participating in the CEPIS programme.  
 
Physician education, training, feedback and support in primary care management of 
depression in elderly were provided to participating GPs. Primary-care physicians 
received 4 hour of training by psychiatrists from the National University Hospital 
Department of Psychological Medicine.  
 
Pharmacotherapy; A pharmacotherapy protocol that included structured assessment 
at initial and follow-up visits and the use of a standard medication algorithm (Figure 2) 
to ensure adequate dosing and duration of treatment was provided. According to the 
protocol, antidepressants were chosen step-wise depending on patient’s response to the 
treatment. Sertraline (Zoloft) was used as the first line antidepressant. 50 mg/day 
dosage was started on elderly without medical comorbidities. However, 25 mg/day 
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was used as starting dosage in older elderly (> 70 years) and those with multiple 
medical comorbidities, and titrated up to 50 mg/day if needed. This dosage was 
continued if the response is good and no side effects were present. The dosage was 
increased up to 75 mg and maximum of 100 mg/ day if no side effects was 
encountered. Venlafaxine (Efexor) (37.5 mg once in the morning) was used as second 
line drug if there is no response at all after 4 weeks of treatment with Sertraline (Zoloft) 
or patients have intolerable side effects on Sertraline (Zoloft). Venlafaxine (Efexor) 
could be increased to twice daily with same dosage. Another alternative to 
Venlafaxine (Efexor) was Mirtazapine (Remeron), which was recommended as a 
better choice for patients with insomnia. The initial dosage was started with 15 mg in 
the night and increased up to 30 mg at night. Combination of antidepressants and 
mood stabilizer were not allowed. The exception was for anti-anxiety drugs for 
depression which was comorbid with anxiety in the treatment programme. 
 
Psychological therapy; The GP may refer the patient for psychological therapy. 
Biweekly 1 hour session of supportive counselling (3 – 5 sessions) was provided if 
patients have a social problems or financial problems.  If patients have maladaptive 
thoughts, low esteem or difficult coping, approximately, 12 to 16 sessions of cognitive 
behaviour therapy (1 hour/session, biweekly) were provided. The psychological 
therapy may be terminated after consulting with the psychotherapist according to 
depression case manager (DCM) regular report on patient progress. 
Psychotherapist used the different types of psychological therapy such as; behaviour 
therapy, cognitive therapy, family therapy and group therapy based on patients’ 
acceptability. Psychotherapist discussed with patient and their caregiver and chose the 
suitable type of psychological therapy. 
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Patient treatment education protocol by trained psychiatric nurses; this was 
conducted in small groups or individually once a week for seven weeks, each session 
lasting 60 min. The educators were nurses who received 12 hours of training and 6 
hours of supervision from psychiatrists. Step-wise patient education sessions were 
provided with a total of 5 sessions. In session I, information on causes, signs and 
symptoms of depression, its treatment options, antidepressant medication and their 
side effects, suicide prevention, communication strategies between depressed patients 
and care giver and ways to prevent burn out were taught to patients, family member 
and their caregivers. In session II, the importance of accepting treatment and 
adherence of treatment was taught. In session III, ways of adopting healthy lifestyle 
changes and scheduling activities to improve mood and maintain wellness were taught. 
In session IV, information about relapse prevention and recognition of early warning 
signs were provided. Finally, the information about relapse prevention plan, adherence 
to treatment and a list of community resources to ask for help were provided in session 
V.  
The Hamilton Depression Scale (HAMD) scale was used to monitor treatment 
response which was rated as ‘No response’ for 20% or less reduction, ‘Partial 
response’ for 21% to 49% reduction and ‘Response’ for ≥ 50% reduction on HAMD 
scores. 
 
Implementation of the intervention 
 
Qualified trained nurse was chosen as depression case manager (DCM). She 
monitored the both groups of nurses who were assigned separately for both 
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intervention and control arms for their implementation of the intervention to ensure 
that the delivery and the standard of the intervention were consistent with the protocol. 
Nurses assess the participants’ compliance of follow up visits to primary caregivers 
and medication through frequent phone calls and visits to their houses and record in 
the patient tracking card. They also monitor the depression signs and symptoms, 
suicide risks, medication record, side effects of antidepressants, referral to counsellor 
and concern of participants and their caregiver about treatment using the patient 
monitoring sheet. The nurses also keep the monthly record of patients ‘participation 
and adherence to the intervention trial. 
DCM makes frequent visits to primary care givers’ clinic and checks the medical 
record and review the progress of treatment. 
 
 
Control Group -Usual Care (UC) 
 
 
The GPs in the control group received none of the physician training or case manager 
or patient education support or feedbacks of GDS screen-positive results that were 
available to the active interventional group of GPs.  They were provided copies of the 
current local practice guidelines on treatment of depression in primary care. Patients 
assigned to the control GPs during the intervention period receive all the usual services 
normally available at the GP’s clinic, including antidepressant medications or referral 






3.5 Assessment for outcomes of CEPIS 
 
The effectiveness of CEPIS outreach programme was evaluated through assessment of 
depressive symptoms, functional status and health related quality of life for individual 
participants at baseline, 3 months and 6 months after randomization and 6 month after 
completion of intervention trial. Follow-up interviews were done by an independent 
assessor who was blinded to treatment assignment. This follow up assessment also 
included subjects (Eligible Non-participant) who were not treated for depression 
because they did not give consent to participate in the treatment trial. The acceptability 
of referral for depression treatment and patient and physician satisfaction of the CEPIS 
programme were also assessed.  
 
3.5.1 Assessment of depressive symptoms and diagnosis of depression 
 
SCID-DSM IV criteria were used for diagnosis of Major Depressive Disorder, Minor 
Depression, and Dysthymia. The 15 item GDS (Yesavage, 1988), Beck Depression 
Inventory (BDI) (Beck, 1961), Hamilton Depression Rating scale (HRSD) (Hamilton, 
1960) were used for assessment of depressive symptoms at baseline, 3 month and 6 
month after randomization and 6 months after intervention. Previous studies (Montorio, 
1996 for GDS; Williams, 2001 for HRSD and Richter, 1998 for BDI) have been 






3.5.2 Assessment of cognitive function 
 
Mini-Mental State Examination (MMSE) (Folstein 1975) was used for cognitive 
function assessment. Memory, attention, language, paraxis and visuo-spatial ability 
domains were measured in this test. The 30 items were coded as zero if the subjects 
refused or were unable to complete. Summed scores of MMSE range from 0 to 30, 
higher values denoting better cognitive functioning. Poor cognitive performance was 
defined by MMSE total score of 18 or less for this study (more than 50% of study 
populations do not have former education). It was validated among Singaporean older 
adults. Cognitive decline was assessed by a decline of 2 or more points in the MMSE 
test scores between baseline and follow-up assessments. 
 
3.5.3 Assessment of functional status - Activities of Daily Living (ADL) and 
Instrumental Activities of Daily Living (IADL)  
 
The ADL scale (Mahoney and Barthel, 1965) and IADL scale (Lawton and Brody, 
1969) were used to assess the respondent’s dependence in performing ADL and IADL. 
Self report and proxy report of ADL and IADL were recorded at baseline and 12 
months. The ADL included 10 items related to basic daily activities; bowel and 
bladder continence, grooming, toilet use, feeding, transfer from bed to chair, mobility 
about the house, dressing, climbing stairs and bathing. The questions were rated from 
‘0’ (Dependent/Unable) to ‘3’ (Independent/Able). 
 
The IADL included eight items such as; making telephone call, travelling alone, 
shopping, preparing meal, housework, handyman work, own laundry, taking 
44 
medication and managing money. The questions were rated from ‘1’ (completely 
unable) to ‘3’ (without help, able to do). 
 
3.5.4 Quality of Life (SF-12) 
 
SF 12 was derived from the 36 item SF 36 health survey (Ware, 1996). Summary 
scores are calculated for two components; physical component summary score (PCS) 
and mental component summary score (MCS). PCS measures physical functioning, 
role physical, bodily pain and general health perception. MCS measures vitality, social 
functioning role, emotional and mental health. The range of scores on SF 12 is 0 to 
100 and higher scores indicate better functioning.  
 
3.5.5 Patients’ satisfaction of CEPIS programme 
 
After the 6 month intervention trial, the participants from the collaborative care (CC) 
programme were interviewed face to face by nurses on their understanding about their 
illness or problem, satisfaction with the advice on how to cope with problem or illness, 
their views about ability of primary care physicians in assessing and managing 
emotional or mental health problem, having access to specialist help if they need it, 
relieving their pain and suffering, recovering from emotional and mental distress, 
returning to their normal activities and overall care and help they received from 
member of CEPIS multidisciplinary team. The response to each question was rated 
with 5 point Likert scale (‘Very satisfied’, ‘Dissatisified’, ‘Neither satisfied nor 
dissatisified’ and ‘Very satisfied’). (Table 14) 
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3.5.6 Physicians’ satisfaction with CEPIS outreach programme 
 
The post intervention survey was done with the physicians (n=15) who provided 
collaborative care for the 6 month duration of intervention for the trial. Several aspects 
of physician’s perception of depression treatment in primary care which consist of 
their satisfaction with current resources available to treat patients with late-life 
depression, their self rated ability to provide quality depression care and their 
perceptions of the effectiveness of CEPIS programme were assessed using a set of 
questionnaires with response categories were on a five-point Likert scale rating from 
‘Strongly disagree’, ‘Disagree’, ‘Neither’, ‘Agree’ and ‘Strongly agree’.(Table 15) 
 
3.6 Statistical Analysis 
 
3.6.1 Study I 
 
The test performance of the GDS was evaluated using receiver-operating 
characteristics (ROC) analyses. Areas under curve (AUC) indicated the accuracy of 
GDS total scores to differentiate clinically diagnosed depression from non-depression, 
and were compared between subgroups using asymptotic tests of significance. 
Sensitivity, specificity, positive and negative predictive value were calculated for 
different cut-off scores and the optimal cut-offs determined. Cronbach’s alpha 
coefficient was used to assess the internal consistency of the GDS-15. Intraclass 
correlation coefficients (ICC) of the GDS total scores were estimated to determine the 
test-retest and the inter-rater reliability. The agreement among raters of the 
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determination of categories of depressed vs. non-depressed (GDS >=5 versus GDS<5) 
was estimated by Cohen's kappa. 
 
3.6.2 Study II 
 
The frequencies of positive responses to individual GDS items were compared among 
gender, age (<75 or ≥75), ethnicity (Chinese or Non-Chinese; Malay, Indian, Others), 
and presence of chronic illness(es), as well as the prevalence of depressive symptoms 
(GDS scores ≥5) and SCID-based diagnoses of MDD.  
Multiple Indicator, Multiple Cause model (MIMIC), a particular form of structural 
equation modelling for latent variable, was used to identify DIF by determining group 
differences in item response, after controlling for respondents’ status on the latent trait 
or factor (Gallo et al., 1994; Grayson et al., 2000; Jones and Gallo, 2002; Niti et al., 
2007, a). The evaluation of DIF was determined by comparing baseline no-DIF and 
DIF models, represented by changes in the Modification Index (MI) statistic. MI is 
related to misfit of a particular model and can be conceptualized as a Chi-square 
statistic with one degree of freedom, that is, the expected drop in overall X2 value if a 
parameter that was fixed to zero is estimated with no constraints in a subsequent 
model (Gallo et al., 1994).  
 
AMOS version 7.0 (Arbuckle, 1995) was used for DIF analyses, and SPSS version 





3.6.3 Study III 
 
Descriptive statistics were used to analysed means (standard deviations) and 
proportions (%), and statistical significance of differences was evaluated using t-tests 
and chi-squared tests. Multiple binary logistic regressions were used to estimate odds 
ratio (OR) of association. 
 
3.6.4 Study IV 
 
We estimated from data in other primary-care studies that follow-up HDRS change 
scores would have an SD of about 7 points. For 80% power of detection of an 
estimated difference of 2·5 points in mean HDRS change score between groups 
(regarded as clinically meaningful) with two-sided significance of 5%, we estimated a 
sample size requirement of 120 patients per group in Collaborative Care (CC) and 
Usual Care (UC).  
 
The primary and secondary analyses were performed on intention-to-treat (ITT) 
patients of UC and CC group. 
 
Baseline characteristics of CC, UC, Eligible but not Participating (ENP) patients were 
compared using X² tests for categorical variables, and t tests for continuous variables. 




For the assessment of  treatment group differences, linear random-effects model was 
used on the continuous outcomes measures and Generalized Estimating Equation 
(GEE) modelling for binary outcomes (except health service use). The models 
included the main effect of treatment, time, their interactions and other covariates 
including age, gender, education, marital status, ethnicity, living arrangement, housing 
type, number of medical conditions. Functional status was additionally adjusted for in 
these models regarding outcomes of depression scores and quality of life. With regard 
to response and remission on depression, we also controlled respective baseline 
depression score. Time was treated as a categorical variable.  When significant 
interaction effects were observed, we did post-hoc between group comparisons of the 
outcomes at baseline and each follow-up. 
 
The analyses were repeated with imputation of missing values by Last Observation 
Carrying Forward (LOCF). RCT analyses were performed using SAS software. (SAS 
Institute, Inc., Cary, NC). Descriptive statistics with SPSS was used for analysis of 
patient satisfaction and physician feedback on CEPIS intervention after the 6 months 
intervention programme. 
 
Descriptive statistics, Chi-square test and Fissure-Exact Test were used for patients’ 
satisfaction and physicians’ feedback about CEPIS programme. 
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 By trained nurses at 3 month, 6 month and 12 month 
GP make regular follow up, decision to change treatment and maintenance plan 
  
  DCM regular report to GP about patient’s progress 
 
     Trained nurses assess treatment response rate with HAMD scale 
              DCM monitors adherence to treatment and compliance to medication 
 




 GP perform clinical assessment and make a clinical diagnosis 
  Trained nurses provide health education and social support  
  DCM arrange to see GP for depression treatment and report GDS 
scores to GP 
         Initial visit with DCM and trained nurses 
      
50 
Figure 1. Flow Chart for CEPIS Intervention  
 
  Consented depressed elderly randomized to intervention (CC) 
Assessment for depressive symptoms, physical function, QOL 
 
GP refer patient to psychiatrists or psychologist whenever necessary 
depressed elderly and care giver 
Make a decision for treatment of choice after discussion with  





                                                          Figure 2. Diagram of treatment algorithm for Major Depressive Disorder (collaborative care) 
                          
Zoloft (50mg/day) 2-4weeks 
(25mg/day in >70yrs, and or poor 
health/multiple medical problems) 
Monitor side effects at all phases 
If intolerable, change of medication 
Not improving Improving well 
No side effects Partial response No response 
Effexor (37.5mg/day, increased to 37.5mg b.d)      
(OR) 
Remeron (15mg/day, increased to 30mg/day) 
Increase dose to 
75mg/day 























4.1 Study I  
 
Criterion-based validity and reliability of the Geriatric Depression Screening 
Scale (GDS-15) in a large validation sample of community-living Asian older 
adults 
 
Study I (and Study II) used data that were analyzed for an initial group of 4253 
participants who were recruited and screened for depression. 
 
The great majority (98.6%) of the respondents (total number of depression screening = 
4253) were users of social and recreational activities centres (care corner centres, 
senior activities centres and neighbourhood links); open-living community sheltered 
and welfare homes residents and day care centre and rehabilitation care facilities; only 
1.4% were residents in nursing home institutions for the aged sick. The mean age was 
73.8 (standard deviation 7.9) years; 43.1% were age between 75 to 79 years old; 
59.0% were female and 90.1% were Chinese. 84.1% reported of having at least one 
chronic medical illness. A total of 338 (7.8%) were found to have GDS scores ≥ 5; 147 
(3.5%) were clinically diagnosed as depression, 0.9% was diagnosed as minor 
depression and 2.6% were diagnosed as anxiety and 0.4% was diagnosed as other 
mental disorders (Table 1).  
 
In our sample, we observed that the test performance of the GDS-15 was excellent 
overall (Table 2) and also in the population subgroups (Table 3).  Overall, the area 
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under the curve was 0.98, sensitivity was 0.96 and specificity was 0.95 at cut-off of 
4/5. Among population subgroups, no clinically significant differences in AUC, 
sensitivity or specificity were noted, although the differences were statistically 
significant because of large numbers. 
 
The Cronbach’s alpha for internal consistency of the 15 GDS scale was 0.80 overall, 
and ranged from 0.65 to 0.84 for different gender, age, ethnicity and chronic illness 
subgroups. Item total correlations ranged from 0.77 to 0.81.  
 
The intra class correlation coefficient of test-retest reliability was 0.83 (95% C.I 0.81-
0.84), suggesting that the GDS-15 was stable over 2 weeks interval of administration. 
The intraclass coefficient of inter-rater reliability was 0.94 (0.90-0.97), and the 




Table 1. Demographic characteristics of study sample (N=4253) 
 
 N % or (SD) 
   
Total sample 4253 100 
   
Sites   
   Social service and sheltered housing 
facilities   
4192 98.6 
   Nursing homes 61 1.4 
   
Age   
   Mean (S.D) 73.8 (7.8) 
   < 75 yrs 2420  56.9 
   ≥ 75 yrs 1833  43.1 
   
Gender   
   Male 1744 41.0 
   Female 2509 59.0 
   
Ethnic   
   Chinese 3830 90.1 
   Non-Chinese* 423 9.9 
   
Chronic medical illness   
    None 676 15.9 
    ≥ 1 3577 84.1 
   
Depressive symptoms 338 7.9 
   
Diagnosis   
    Major depressive disorder 147 3.5 
    Minor depression 38 0.9 
    Anxiety 109  2.6 
    Others 15  0.4 
   
 
 













                  Table 2. Validity parameters of 15-GDS for varying cut-offs in whole sample 
Cut-off: Sensitivity Specificity Positive predictive value 
Likelihood ratio 
for positive test 
2/3 0.97 (0.95-0.99) 0.83 (0.82-0.84) 0.17 (0.15-0.19) 5.77 (5.36-6.21) 
3/4 0.96 (0.94-0.99) 0.91 (0.90-0.92) 0.28 (0.24-0.31) 10.63 (9.61-11.77) 
4/5 0.96 (0.94-0.99) 0.95 (0.94-0.96) 0.42 (0.36-0.47) 20.24 (17.59-23.28) 
5/6 0.89 (0.84-0.94) 0.96 (0.95-0.97) 0.47 (0.40-0.52)  24.23 (20.51-28.62) 
6/7 0.80 (0.73-0.86) 0.97 (0.97-0.98) 0.51 (0.45-0.58) 29.44 (24.08-35.99) 
7/8 0.73 (0.66-0.80) 0.98 (0.98-0.99) 0.58 (0.51-0.65) 38.82 (30.46-49.46) 










Table 3. Criterion validity of GDS-15 (cut-off 4/5) as screening instrument for major depressive disorder by age, gender, ethnicity, 
 and presence of chronic medical conditions (N=4253)  











for positive test† 
        
Overall 0.80 (0.79-0.81) 3.5 0.98 (0.97-0.99) 0.96 (0.94-1.00) 0.95 (0.95-0.96) 0.43 (0.37-0.47) 20.2 (17.6-23.3) 
Gender        
Male   0.81 (0.80-0.83) 3.6 0.98 (0.96-0.99) 0.98 (0.95-1.02) 0.95 (0.94-0.96) 0.42 (0.34-0.50) 19.0 (15.5-23.4) 
Female  0.79 (0.78-0.80) 3.3 0.97 (0.96-0.99) 0.95 (0.91-1.00) 0.96 (0.95-0.96) 0.42 (0.35-0.49) 21.2 (17.5-25.6) 
        
Age        
<75 years 0.82 (0.81-0.83) 3.9 0.98 (0.97-0.99) 0.96 (0.92-1.00) 0.95 (0.94-0.96) 0.44 (0.38-0.52) 19.9 (16.5-23.9) 
75 years or older 0.77 (0.75-0.79) 2.8 0.98 (0.96-0.99) 0.98 (0.94-1.02) 0.95 (0.94-0.96) 0.38 (0.30-0.46) 20.8 (16.8-25.7) 
        
Ethnic        
Chinese 0.80 (0.78-0.81) 3.4 0.98 (0.97-0.99) 0.97 (0.94-1.00) 0.95 (0.95-0.96) 0.42 (0.37-0.48) 20.5 (17.7-23.8) 
Non-Chinese# 0.84 (0.82-0.86) 3.8 0.98 (0.96-1.00) 0.94 (0.82-1.00) 0.95 (0.93-0.97) 0.41 (0.26-0.58) 18.2 (11.8-28.1) 
        
Chronic conditions        
None 0.65 (0.61-0.70) 0.7 0.98 (0.96-0.99) 1.00 (0.57-1.00) 0.98 (0.97-0.99) 0.26  (0.12-0.49) 50.0 (10.0-99.0) 
At least 1 0.81 (0.80-0.82) 4.0 0.99 (0.99-1.00) 0.97 (0.93-1.00) 0.95 (0.94-0.96) 0.43 (0.38-0.48) 18.2 (15.7-21.0) 
        
* Differences in areas under the curves were all statistically significant at p << 0.01. 
None-Chinese#: Malay, Indian, Others 
# Cardiac diseases, hypertension, diabetes, stroke, eye disorders, arthritis, hip fracture, cancer, kidney failure, urinary problems, asthma/ COPD, other chronic 
medical conditions  
Figures in parenthesis indicate 95% confidence limits, asymptotic tests, under non-parametric assumptions; †Based on score method 
 
 
4.2 Study II Differential Item Functioning (DIF) of the Geriatric Depression Scale in 
an Asian population 
 
In study II, we further analysed study I data to identify the factors related to differential 
item functioning of GDS. Table 4 shows the frequencies of individual items of depressive 
symptoms reported by different gender, age, ethnic and chronic illness groups, together 
with the prevalence of cases with GDS≥5 and MDD among them. MDD was significantly 
more prevalent among younger (<75) compared to older (≥75) elderly (P<0.05), and in 
those with chronic illnesses (p<0.001). However, GDS≥5 cases were not significantly 
greater in younger compared to older elderly, mainly because a few GDS items (2, 9, 10, 
12, and 13) were more commonly reported in older elderly. On the other hand, the higher 
prevalence of MDD in those with chronic illnesses and the pattern of GDS items and 
GDS≥5 cases appeared to be consistent. For gender and ethnicity, no significant 
differences in GDS≥5 case and MDD case prevalence were observed, and although the 
pattern of a few GDS items appeared to be at variance, they did not appear to cause any 
discordance of the GDS caseness with MMD caseness.  
 
These item performances of the GDS may possibly but not necessarily result in 
differences in test performance of the GDS among different population subgroups.  
In Table 4, there appeared to be no major discrepancies in the prevalence of depressive 
symptoms (GDS≥5) vis-à-vis MDD by gender, ethnicity or chronic illness. However, for 
the two different age groups, the first indication of GDS test bias was the discrepancy in 
prevalence of depressive symptoms vis-à-vis prevalence of MDD. Whereas the 
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prevalence of MDD was significantly higher in younger versus older elderly, the 
difference in depressive symptoms (GDS≥5) between them was small and not statistically 
significant.   
 
As indicated by differences in individual endorsed GDS items in Table 4 and confirmed in 
the MIMIC model (Table 5), six items were determined to have significant age-related 
DIF; five items gender-related DIF, four items ethnicity-related DIF and two items 
illness-related DIF.  Altogether 10 items evidenced some degree of DIF on one or more 
factors. Of these, two items had a borderline magnitude of MI and were involved in just 
one single factor (gender or age). Without those two items, eight items of the GDS-15 
remained that had significant DIF. These were ‘dropped many activities and interests’, 
‘afraid something bad is going to happen’, ‘prefer staying home to going out’, ‘more 
problems with memory than most’, ‘think it is (not) wonderful to be alive’, ‘feel pretty 
worthless’, ‘feel (not) full of energy’, ‘feel that situation is hopeless’. 
We removed those response bias items and formed the shorter version, response bias free 
7-items GDS. This shorter version is user friendly and time efficient for primary care 
giver to identify the depression cases with high accuracy. We will do the factor analysis 
and validation study for 7-items GDS in our future studies. 
  Table 4. Item analysis of the GDS-15 by age, gender, ethnicity, and presence of any chronic illness (N=4253) 
Age  Gender Ethnicity  Chronic Illness#  GDS-15 items Whole 
sample <75 ≥75 P  Male Female p Chinese Non-
Chinese
p  No Yes p 
                  
 No. of respondents  2420 1833   1744 2509   3830 423   676 3577  
                  
1 Basically (not) satisfied 
with life 
5.1 5.5 4.5 0.14  6.9 3.8 <0.001  4.8 7.6 0.02  3.0 5.5 0.03 
2 Dropped many activities 
and interests 
6.4 5.0 8.2 <0.001  6.8 6.1 0.34  6.1 8.5 0.06  4.3 6.8 0.02 
3 Feel that life is empty 9.6 9.7 9.5 0.78  11.5 8.3 <0.001  9.5 10.2 0.70  5.5 10.5 <0.001 
4 Often get bored 8.6 8.5 8.7 0.76  10.6 7.2 <0.001  8.5 9.5 0.52  4.2 9.5 <0.001 
5 (Not) in good spirits most 
of the time 
7.4 7.5 7.2 0.62  7.9 7.0 0.26  7.1 9.5 0.09  3.4 8.2 <0.001 
6 Afraid something bad is 
going to happen 
14.1 15.0 13.0 0.06  13.3 14.7 0.17  14.3 12.3 0.24  10.9 14.8 0.004 
7 Feel (not) happy most of 
the time 
7.2 7.8 6.5 0.07  8.0 6.7 0.14  7.0 9.2 0.11  3.4 8.1 <0.001 
8 Feel helpless 8.8 8.4 9.4 0.27  9.6 8.3 0.13  8.9 7.8 0.41  5.2 9.6 <0.001 
9 Prefer staying home to 
going out 
15.6 13.8 17.9 <0.001  13.5 17.0 0.002  16.0 11.6 0.02  12.6 16.2 0.05 
10 More problems with 
memory than most 
19.9 16.0 25.0 <0.001  17.8 21.3 0.01  20.7 12.1 <0.001  16.3 20.6 0.01 
11 Think it is (not) wonderful 
to be alive 
6.5 6.4 6.7 0.68  7.1 6.1 0.20  6.7 4.7 0.12  3.0 7.3 <0.001 
12 Feel pretty worthless 15.5 12.8 19.1 <0.001  16.1 15.1 0.43  16.0 11.1 0.01  8.9 16.9 <0.001 
13 Feel (not) full of energy 10.2 8.7 12.1 <0.001  9.9 10.4 0.55  9.8 13.2 0.03  4.6 11.4 <0.001 
14 Feel that situation is 
hopeless 
11.1 10.7 11.6 0.42  14.2 8.9 <0.001  11.2 9.9 0.41  6.9 12.0 <0.001 
15 Think that most people 
are better off 
8.4 9.1 7.5 0.06  10.0 7.3 0.001  8.2 10.6 0.09  6.3 8.9 0.002 
                  
 GDS total score ≥5 7.9 8.3 7.3 0.22  8.5 7.4 0.23  7.8 8.5 0.60  3.5 8.8 <0.001 
                  
 Major depressive disorder 
by SCID 
3.4 3.9 2.8 0.049  3.6 3.3 0.64  3.4 3.8 0.70  0.7 4.0 <0.001 
                  
Figures are in percentage (%);#Cardiac diseases, Hypertension, DM, Stroke, Eye disorders, Arthritis, Hip fracture, Cancer, kidney failure, Urinary problems, 




Table 5. GDS-15 items with significant differential item functioning (DIF) by age, gender, ethnicity, 
and presence of any chronic illness shown in MIMIC analysis 







        
1. Basically (not) satisfied with life    6.6     
2. Dropped many activities and interests 10.2       
3. Feel that life is empty         
4. Often get bored        
5. (Not) in good spirits most of the time        
6. Afraid something bad is going to happen   8.2     
7. Feel (not) happy most of the time 7.1       
8. Feel helpless        
9. Prefer staying home to going out 7.9  12.5  6.4   
10. More problems with memory than most 47.0  9.2  25.3   
11. Think it is (not) wonderful to be alive     8.2   
12. Feel pretty worthless 31.5    7.9  5.3 
13. Feel (not) full of energy 9.6      14.7 
14. Feel that situation is hopeless   18.3     
15. Think that most people are better off        
        
Figure shown are values of MI (Modification Index); Items 1; 2; 6; 7; 9; 10; 11; 12; 13; 14 were considered for 
exclusion: 
#Cardiac diseases, Hypertension, DM, Stroke, Eye disorders, Arthritis, Hip fracture, 






4.3 Study III Improving treatment access and acceptance for depression in a 
national community-based outreach programme for the elderly 
 
Among the invited social service centres, community day care centres and welfare/old 
aged homes and nursing homes across island wide, almost all of neighbourhood link, 
senior activity centres and 3 quarters of community sheltered/welfare homes and 
neighbourhood GP participated in the study. However, only less than a quarter of nursing 
homes and day rehabilitation centres agreed to participate in the study (Table 6). 
 
From a total of 8181 individuals in the nominal contact list, 6161 seniors were 
successfully contacted. Among the latter, depression screening could not be performed on 
1180 seniors because 14 died before interview, while the rest were either cognitively 
impaired or demented (398), physically incapacitated (327) or had communication 
difficulties (441). The proportions of successful contacts who were found suitable for 
screening was 96% for all users of senior activity centres and neighbourhood links, 50.4% 
in sheltered/welfare home and day care centres, and 13.2% for nursing homes. Among 
4981 seniors who were eligible for screening, 348 (7%) refused and 4633 seniors 
participated in the screening interviews (Figure 3).  
 
The data analysis performed upon the final completion of depression screening 
programme involved 4633 participants in the outreach programme. They comprised 79% 
who were users of social and recreational centres, 9.5% who used day care and 
rehabilitation centres, 9.9% who lived in community sheltered/welfare homes and 1.4% 
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who were residents of nursing homes. The stigma of family members of the elderly users 
in day care and rehabilitation centres caused low participation rate and, whereas in 
nursing home, most of the residents were physically and mentally unfit for the interview 
(Figure 4). 
 
Their mean age was 73.7 (SD,7.9), 66.5% were 70 years old and above; 58.5% were 
female, the majority were Chinese (89.3%); 50.7% had no formal education; 45.1% were 
separated, divorced or widow; 63.8% resided in low-end public housing apartments, 
welfare, sheltered or nursing homes, 29.2% stayed alone; 36.1% self reported having 3 or 
more chronic medical diseases (Table 7). 
 
A total of 370 seniors were screened positive for depressive symptoms (8%). They 
included 151 (40.8%) who were determined to have major depressive disorder (including 
69 comorbid with other disorders). With additional cases of anxiety and psychotic 
disorders, a total of 214 (57.8%) seniors with mental disorders were found (Table 8). 
Although symptomatic, less than a quarter of those with depressive symptoms reported 
that they had a mental disorder, or that their mental health was poor, or perceived that 
they needed help for their mental or emotional problems, and only 1 in 10 of them had 
spontaneously sought treatment for mental problems in the past year.  
 
As a result of nurses’ visits and follow-through psychoeducation, 274 (74.0%) of seniors 
with depressive symptoms were successfully referred to a GP for further assessment and 
treatment. An additional 36 seniors with depressive symptoms were not referred to 
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general practitioners because they were already under psychiatric treatment, or were 
referred for specialist psychiatric treatment because of severe symptoms or suicidality. 
 
Among 370 participants with depressive symptoms, we examined in multivariate analyses 
variables that were independently associated with spontaneous treatment-seeking prior to 
the programme (Table 9). In the presence of SCID diagnosis of mental disorder (OR=2.22, 
p=0.03), fair or poor self-reported mental health (OR=3.26, p=0.04), presence of ≥10 
depressive symptoms (OR=3.18, p=0.004), and perceived need for help (OR=3.58, 
p=0.001), non-need variables that showed significant associations were presence of ≥3 
medical illnesses (OR=2.67, p=0.02),  younger age less than 70 (OR=2.55, p=0.02), 
female gender (OR=3.58, p=0.01), and at least primary education (OR=3.06, p=0.01) 
(Table 9).  
 
In the same analysis performed on treatment acceptance through the CEPIS programme, 
no significant associations were shown except for living in low-end public housing 
apartments, sheltered and nursing homes (OR=2.79, p<0001), and presence of 3 or more 
chronic medical illnesses (OR=0.59, p=0.04) (Table 9). 
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Table 6. Response rates of screening sites and GPs in CEPIS GDS screening
No Type Total No No of participating sites Refused Response rate 
and GPs  %
1 Day care centers for Elderly 19 12 6 63.16
2 Day Rehabilitation center 27 6 21 22.22
3 Neighbourhood Links 22 21 1 95.45
4 Seniors Activity Centers 22 22 0 100.00
5 Sheltered/Welfare Homes 20 15 5 75.00
6 Nursing Homes 29 4 25 13.79
7 General Practitioners 41 31 10 75.61  














Characteristics  N % 
    
Sites    
   Care corner, Senior activities centre, Neighbourhood link  3677 79.4 
   Day care/Rehabilitation centre  438 9.5 
   Community Sheltered homes/old aged homes  454 9.8 
   Nursing homes   64 1.4 
    
Age    
Mean age, mean (SD)  73.71 7.89 
   60-69  1553 33.5 
   70-79  1983 42.8 
   80 and above  1097 23.7 
    
Gender    
   Male  1922 41.5 
   Female  2711 58.5 
    
Ethnicity    
   Chinese  4139 89.3 
   Malay  312 6.7 
   Indian  141 3.0 
   Others  41 0..9 
    
Educational level    
   No formal education  2348 50.7 
   Primary education level  1707 36.8 
   Secondary education level and above  578 12.5 
    
Marital status    
   Never married  1066 23.0 
   Married  1477 31.9 
   Separated, divorced, widowed  2090 45.1 
    
Housing type    
   1, 2 rooms HDB flat  2734 59.0 
   3, 4 rooms HDB flat  1203 26.0 
   5, executive, condominium and landed house  696 15.0 
    
Living arrangement    
   Live alone  1353 29.2 
   Live with partner, spouse, child, extended family  1709 36.9 
   Live with friends & others such as relatives or lived in sheltered/old aged 
homes 
 1496 32.3 
   Nursing home  75 1.6 
    
Co-morbid medical conditions    
   None  787 17.0 
   1-2  2146 46.3 









Table 8. Prevalence of Psychiatric Morbidities, Perceived Need and treatment acceptance in Screened 
population (N=4633) 
                





 N % N %  
      
Depressive symptoms (GDS ≥5) 370 8.0 370 100  
Major depressive disorder alone 84 1.8 82 22.2  
Co-morbid depressive disorder, anxiety or other 
psychiatric disorders 
73 1.6 69 18.6  
Anxiety and psychotic disorders 109 2.4 63 17.0  
Any psychiatric disorders (SCID) 266 5.7 214 57.8  
      
Self reported mental health status; Poor    94 2.0 65 17.6  
                                                  Fair    1660 35.8 201 54.3  
                                                  Good, very good & 
excellent 
2879 62.1 104 28.1  
Self report of a mental health disorder 144 3.1 72 19.5  
Perceived need for professional treatment 116 2.5 82 22.2  
Sought treatment spontaneously before the programme 92 2.0 38 10.3  
Accepted treatment in the programme 274 5.9 274 74.0  








Table 9. Variables associated with spontaneous help seeking and with acceptance of treatment through the CEPIS programme among 
participants with depressive symptoms (N=370) 
 Pre-outreach spontaneous sought treatment  (38/ 370)  Acceptance of treatment through outreach programme (274/ 334) † 
 N % P (χ2 test) AOR 95% CI P (Wald)  N % P (χ2 test) AOR 95% CI P (Wald) 
              
Total 38 10.3      274 82.0     
              
Service sites;              
Social and recreational service centres (N=282) 33 11.7      208 73.8     
Residential and day care/rehabilitation centres (N=88) 5 5.7 0.10 0.67 0.23-1.90 0.45  62 70.5 0.54 0.99 0.55-1.78 0.98 
              
Age: ≥ 70 (N=227) 15 6.6      101 70.6     
        60-69 (N=143) 23 16.1 0.003 2.55 1.18-5.52 0.02  169 74.4 0.42 0.86 0.51-1.44 0.56 
              
Gender:  Male (N=165) 9 5.5      125 75.8     
               Female (N=205) 29 14.1 0.006 3.58 1.45-8.84 0.01  145 70.7 0.28 0.86 0.49-1.48 0.58 
              
Ethnicity: Non-Chinese (N=48) 2 4.2      233 72.4     
               Chinese (N=322) 36 11.2 0.14 3.57 0.78-16.44 0.10  37 77.1 0.49 0.86 0.40-1.84 0.70 
              
Education: None (N=185) 15 8.1      134 72.4     
                 Primary & above (N=185) 23 12.4 0.17 3.06 1.34-7.03 0.01  136 73.5 0.82 0.98 0.57-1.67 0.93 
              
Marital status: Married, never married (N=190) 19 10      140 73.7     
                      Separated, divorced, widowed (N=180) 19 10.6 0.86 1.29 0.59-2.84 0.53  130 72.2 0.75 0.88 0.52-1.48 0.62 
              
Housing type: 3,4, 5 rooms, condo, landed homes (N=115) 14 12.2      66 57.4     
                       1, 2, rooms, old aged homes (N=255) 24 9.4 0.42 0.85 0.37-1.94 0.69  204 80 <0.001 2.79 1.64-4.75 <0.001 
              
Living arrangement: With family, Others (N=244) 22 9.00      172 70.5     
                                Live alone (N=126) 16 12.70 0.27 1.02 0.44-2.35 0.96  98 77.8 0.14 1.13 0.62-2.04 0.70 
              
Co morbid medical illness: None or ≤ 2 (N=175) 10 5.7      138 78.9     
                                           ≥ 3 (N=195) 28 14.4 0.01 2.67 1.19-5.99 0.02  132 67.7 0.02 0.59 0.36-0.98 0.04 
              
SCID diagnosis: Negative *(219) 16 7.3      157 71.7     
                           Positive (151) 22 14.6 0.02 2.22 1.06-4.66 0.03  113 74.8 0.50 1.20 0.73-1.97 0.47 
              
Self rated mental health status *              
   Excellent, Very Good, Good (N=104) 4 3.8      78 75.0     
   Fair & poor  (N=266) 34 12.8 0.01 3.26 1.07-9.91 0.04  192 72.2 0.58 0.83 0.48-1.46 0.52 
              
Depressive symptoms < 10 (N =253) 17 6.6      190 73.6     
Depressive symptoms ≥10 (N=117) 21 18.0 <0.001 3.18 1.45-6.96 0.004  80 71.4 0.66 0.91 0.52-1.58 0.73 
              
Perceived need for help: No *(N=288) * 18 6.3      215 74.7     
                                        Yes (N=82) 20 24.4 <0.001 3.58 1.66-7.75 0.001  55 67.1 0.17 0.82 0.46-1.47 0.50 
              
† The number is less than 370 because 36 participants were not eligible to be referred for treatment in the programme (under psychiatric care, suicidal, etc). 
Added individually to base model that included screening sites, age, gender, ethnicity, educational level, marital status, housing types, living arrangement, comorbid medical illness and 
SCID diagnosis. P values are derived from chi-squared tests and Wald tests of statistical significance
4.4 STUDY IV  
 
Randomized Controlled trial comparing collaborative shared care versus usual care 
to evaluate the effectiveness of CEPIS outreach programme 
 
A total of 4633 community dwelling elderly (≥ 60 years) completed the depression 
screening. Among them, 376 were screened positive for depression and assessed for 
eligibility to participate in intervention trial. After excluding 42 non-eligible elderly, 334 
were invited for participation in the trial. Among them, 60 eligible elderly refused, and 
274 who consented were randomized to intervention (CC) or control (UC) treatments. 
Among them, 27 out of 139 UC group and 33 from 135 CC group subsequently withdrew 
from the trial. Finally, 112 UC and 102 CC participated fully in the trail. At 12 month 
assessment, 90 UC and 91 CC completed the assessment; 25 UC (28%) and 9 CC (10%) 
discontinued treatment. Eligible persons who refused to participate (60) and those who 
withdrew after randomization (60) were grouped as Eligible Non-Participant (ENP = 120) 
and followed up at 3 month, 6 month and 12 month and assessed in the same way as trial 
participants. Among them, only 68 ENP completed the 12 month assessment; 43.3% did 
not complete the assessment. (Figure 5) 
 
All the participants from CC group completed the education protocol provided by trained 
nurses through 5 to 7 smaller sessions based on dialect group. Only 3 participants from 
CC group were referred to counsellor for the psychological therapy by primary care givers. 
They received average 5 sessions over the period of 2 months. We found that the 
participants from CC group adhered to their medication and follow up visits for their 
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treatment with the support of the nurses. Whereas in UC group, those participants live 
alone failed to adhere the regular follow up visits for the treatment because of the lack of 
social support . 
 
 
We compared socio-demographic data using Chi-square test to assess any difference 
among usual care (UC), collaborated care (CC) and Eligible Non Participants (ENP).  
Table 10 shows the baseline characteristics of the 334 elderly subjects. Overall, 55.4% 
were male, 51.0% were illiterate, 27.5% were married, 86.8% were Chinese, 28.7% lived 
in one room HDB or old aged room and 34.4% lived alone. The mean age of patients was 
73.1(±8.2 SD) and the average number of illnesses was 2.8(±1.70SD). At baseline, the 
mean scores of HAMD, GDS and BDI were 7.8(±5.49 SD), 7.8(±2.72SD) and 
15.4(±7.96SD) respectively. The socio-demographic characteristics did not differ 
significantly among UC, CC  and ENP groups, except for housing type P=0.016), baseline 
scores of HAMD (P=0.02) and GDS (P=0.042).     
 
In table 11, comparisons of adjusted mean scores of 3 groups revealed a significant 
difference between groups in the change of depressive severity and MCS but not for PCS 
and functional status. Significant improvement was found in HAMD in both CC and UC 
groups as opposed to ENP group over the follow-up. At baseline, both the CC (p=0.015) 
and UC (p=0.006) groups scored more poorly than ENP group, but the differences 
disappeared at 3 follow-up. This showed greater improvement on the HAMD in CC and 
UC groups than ENP group. However, there was no difference in improvement in HAMD 
between UC and CC.  
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 When GDS score was examined, it was significantly decreased in all the 3 groups over the 
12 months. Although UC group scored significantly better than CC group on GDS at 
baseline (p=0.016), the reverse was observed at 3 months (p=0.030) and 6 months 
(p=0.018), and the difference became less pronounced and not significant at 12 months. 
Comparison of GDS between CC and ENP groups revealed that despite the difference 
being in favour of ENP patients at baseline (p=0.015), CC patients fared significantly 
better at 6 month follow up (p=0.008) and 12 month follow-up (p=0.041). Conversely, 
improvement in GDS was comparable for UC patients versus ENP patients.  
 
Similar to GDS, we also observed significant decline in mean score of BDI in all the 3 
groups. Comparison of CC and UC showed that the difference in mean score of BDI was 
not significant at baseline, but became significant at 3 months (p= 0.006) and 6 months 
(p=0.041), with scores being lower in the CC group than UC group, and not significant at 
12 month. In comparisons between CC and ENP patients, CC patients showed 
significantly greater improvement in BDI score than did ENP patients at 6 month 
(P=0.004) but not at 12 month. In contrast, there was no difference in the mean BDI 
scores at all assessment points between UC patients and ENP patients. 
 
Regarding quality of life, patients in both the CC and UC groups reported significant 
improvements  in MCS in contrast to those in ENP group, with CC patients showing 
greater improvement on MCS than UC at 6 months (P=0.023). Although patients in CC 
group have lower MCS score than ENP group at baseline (P=0.014), the difference 
diminished at later follow-ups. The change in the MCS of the UC patients over time did 
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not seem to be different from ENP patients.  However, there was no evidence of 
beneficial effects for the CC group on the PCS, ADL and IADL. The difference between 
UC and CC group in PCS at 3 months was not statistically significant and not meaningful.  
 
Intervention effects based on 50% reduction of depression score and remission (GDS≤5) 
at the 3 month, 6 month and 12 month follow-ups are reported in table 12. The group by 
time interaction was not significant in all the models. Unlike BDI, when assessed by GDS 
or HAMD, patients of the CC group had significantly (or marginally) greater odds of 
favourable response compared with those of UC groups over 1 year. But comparison of 
CC and ENP group consistently indicated a higher response rate of patients of CC groups 
than ENP group across all 3 indexes of depression. Conversely, patients in the UC group 
responded at a comparable rate to those of ENP group for both GDS and HAMD, but 
better when assessed by 50% reduction of BDI from baseline. With regard to remission 
rate, patients of the CC group were more likely to achieve remission than those of UC and 
ENP groups, but remission rate was not significantly different between UC and ENP 
group. 
 
In Table 13, multiple logistic regressions was performed to explore group differences in 
health service use. We did not find any significant differences in the odds of 
hospitalization or doctor visit between the 3 groups. The results did not change with re-
analysis with imputation of missing data. 
 
All the trial participants were interviewed face to face with trained nurses for their 
satisfaction about the CEPIS programme after 6 months intervention period. We used 
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semi-structured questions related to the patient’s understanding of disease and problem, 
their view about accessing GP and specialists, returning to normal functional activities 
after treatment and their view about CEPIS programme. Responses were scored on 5 point 
Likert scales, from ‘Very dissatisfied’, ‘Dissatisfied’, Neither satisfied nor dissatisfied’, 
‘Satisfied’ to ‘Very satisfied’ .  
 
From our survey, we found that patients in the CC groups were significantly more likely 
to response “Very satisfied” with the advice, overall care and help they received from the 
doctors, depression care manager and nurses to cope with their problem and illness, 
ability of their doctors to assess and manage their emotional mental health, and their 
recovering and relieving of pain and suffering from their emotional and mental distress, 
than patients in the UC group (Table 14.2-3, 14.7-10). Significantly higher number of CC 
group patients responded “Satisfied” to the practical support they received for their 
recovery, compared to those of UC group (Table 14.6). Our results also showed that the 
number of UC group patients, responded “Neither satisfied nor dissatisfied” to 
understanding of problem and illness, the advice and practical support to cope with their 
illness and to get recovery, was significantly higher than that of CC group (Table 14.1, 
14.2, 14.4, 14.6, and 14.8). 
 
A total of 15 intervention GPs were asked to give their feedback about the CEPIS 
structured shared care intervention and its effectiveness in improving the assessment and 
management of emotional problem and mental health illness. More than two thirds of the 
GPs agreed that they were more confident about diagnosing and treating patients with 
depression, as a whole, the structured, multi-faceted, shared care was applicable in 
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primary car practice for managing patients with depression, that it produced more 
satisfactory results in managing patients with depression, that it can be replicated under 
most conditions, it supports and facilitates continuity of care, it was a good model for 
improving primary care of depressed patients, they will continue to participate in it given 
the right conditions, and that they will strongly encourage MOH and the College of GP to 
support this primary care strategy. The least favourable feedback was from 2 GPs (13%) 








































                                                                                                      
                      Figure 5. CONSORT Flow chart of CEPIS RCT 
Screened subjects  (n=4633) 
Excluded :GDS<5 (n=4263) 
Assessed for eligibility (n=370) 
Excluded due to in-eligibility  
(n=36) 
Eligible subjects (n=334) 






Baseline: Usual care  
(n=112) 




Eligible but refused (n=60)
Baseline: Eligible non-
participants (n=120)
12 month:  
Completed (n=90) 
Uncompleted (n=32) 
-   Lost to follow-up (n=4) 
 -  Discontinued care (n=21) 
 -  Physically unfit (n=4) 
   Die (n=3) -
 
 
12 month:  
Completed (n=91) 
Uncompleted (n=11) 
 -  Lost to follow-up (n=2) 
  - Discontinued care (n= 7) 
 -  Physically unfit (n=1) 
 -  Die (n=1) 
 
 
12 month:  
Completed (n=68) 
Uncompleted (n=52)
                                                            
 
















 Age 73.1 (SD 8.2) 72.5(8.46) 73.5(7.79) 73.5(8.21) 0.561  Male, 149 (55.4%) 54(45.0) 53(47.3) 42(41.2) 0.661  Illiterate, 164 (51%) 60(50.0) 57(50.9) 47(46.1) 0.758  Married, 92 (27.5%) 39(32.5) 33(29.5) 20(19.6) 0.086  Chinese, 290 (86.8%) 108(90.0) 96(85.7) 86(84.3) 0.419 
One room HDB or  
old age room, 96(8.7%) 
45(37.5) 23(20.5) 28(27.5)  0.016  













Table11.  The adjusted means in 3 different groups and least square mean score differences between UC, CC VS. ENP groups over 





























 Adjusted mean score difference (95%C.I.)    Interaction¶ 
          CC vs. UC UC  vs. ENP   CC vs. ENP  X2 P  df 
Depressive 
symptoms 
                 
  HAMD-17  0 304 8.1(0.65)  9.9(0.62)  10.1(0.62)  0.2(-1.2 to 1.6) 1.9 (0.3 to 3.4) §  2.1 (0.6 to 3.5) §  22.6 0.001 6 
  3 250 7.7(0.77)   8.0(0.64)*   7.0(0.59)*  -1.1(-2.4 to 0.3) 0.3 (-1.4 to 2.0)  -0.8 (-2.4 to 0.8)     
  6 277 7.6(0.65)  7.9(0.62)  6.7(0.65)  -1.3(-2.6 to 0.1) 0.3 (-1.1 to 1.8)  -0.9 (-2.4 to 0.5)     
  12 249 8.0(0.90)  7.0(0.70)*  7.2(0.71)  0.2(-1.4 to 1.8 ) -1.0 (-3.0 to 1.0)  -0.8 (-2.8 to 1.2)     
                  
  GDS  0 334 7.9(0.37)  8.0(0.33)  8.8(0.37)  0.8(0.2 to 1.5) § 0.1 (-0.6 to 0.8)  0.9 ( 0.2 to1.7) §  24.7 0.0005 6 
  3 250 5.9 (0.60)*   6.0 (0.44)*  4.9(0.45)*  -1.1(-2.1 to -0.1) § 0.1 (-1.1 to 1.4)  -1.0 (-2.2 to 0.3)     
  6 277 5.7(0.53)  5.4(0.44)  4.2(0.45)*  -1.2(-2.2 to -0.2) § -0.3 (-1.5 to 0.8)  -1.6 (-2.7 to -0.4) §     
  12 249 5.9(0.55)  5.1(0.44)  4.6(0.48)  -0.6(-1.7 to 0.5) -0.7 (-1.9 to 0.5)  -1.3 (-2.5 to -0.1) §     
                  
  BDI  0 317 15.4(0.91)  17.6(0.87)  16.4(0.87)  -1.2(-3.2 to0.9) 2.2 (0 to 4.4 )  1.0 (-1.1 to 3.1)  22.2 0.001 6 
  3 250 9.6 (0.89)*   10.5 (0.70)*  8.4(0.70)*  -2.0(-3.5 to -0.6) § 0.9 (-0.9 to 2.7)  -1.1(-2.9 to 0.7)     
  6 277 10.8(0.82)  10.0(0.73)  8.3(0.76)  -1.7(-3.3 to -0.1) § -0.8 (-2.6 to 0.9)  -2.5(-4.2 to -0.8) §     
  12 249 10.0(1.03)  8.5(0.80)*  9.1(0.87)  0.7(-1.3 to 2.6) -1.6 (-3.9 to 0.7)  -0.9(-3.3 to 1.4)     
                  
Quality of Life                  
  PCS  0 304 40.9(1.06)  40.0(1.16)  41.4(1.03)  -1.4(-1.0 to 3.8) -1.0 (-3.4 to 1.5)  0.5 (-1.9 to 2.8)  13.6 0.036 6 
  3 248 39.6(1.35)  38.4(1.16)  41.6(1.13)  3.2(0.7 to 5.8) § -1.2 (-4.2 to 1.7)  2.0 (-1.1 to 5.1)     
  6 277 41.5(1.27)  39.7(1.11)  40.1(1.14)  0.40(-2.1 to 2.9) -1.8 (-4.6 to 1.0)  -1.4 (-4.3 to 1.5)     
  12 246 40.1(1.15)  40.8(1.20)  41.8(1.16)  1.0(-1.8 to 3.7)  0.8  (-1.9 to 3.5)  1.8 (-0.9 to 4.4)     












¥ : ENP: Eligible non- participants; UC: usual care; CC: collaborative care. 
¶:  interaction between time from baseline and group 
*: A statistically significant change occurred in comparison with the value at the previous time point.  
§: Mean score difference is significant at 0.05 level.  
      
  MCS  0 304 39.6(1.42)  37.3(1.22)  35.8(1.34)  1.5(-4.3 to 1.2) -2.2 (-5.2 to 0.7)  -3.8 (-6.8 to -0.8) §  16.5 0.011 6 
  3 248 40.5 (1.63)   40.3 (1.34)*   40.9(1.47)*  0.6(-2.7 to 3.9) -0.3 (-3.8 to 3.2)  0.3 (-3.3 to 4.0)     
  6 277 41.3(1.44)  40.5(1.26)   43.8(1.32)*  3.3(0.5 to 6.2) § -0.8 (-3.9 to 2.3)  2.5 (-0.5 to 5.6)     
  12 246 42.2(1.56)   43.6(1.27)*  43.7(1.39)  0.04(-3.1 to 3.1) 1.5 (-1.8 to 4.8)  1.5 (-1.9 to 5.0)     
                  
Functional status                  
Score of ADL  0 317 18.9(2.20)  19.3(2.59)  19.3(2.21)       3.2 0.530 4 
  6 277 18.6 (3.10)   18.8 (2.51)   18.7(2.69)          
  12 249 18.3(3.65)  18.9(2.82)  19.0(1.73)          
                  
Score of IADL  0 304 22.7(4.61)  23.3(4.07)  22.7(4.17)       8.0 0.091 4 
  6 277 22.2(5.28)   22.7(4.97)  23.1(4.54)          
  12 249 21.9(5.52)  23.1(3.74)  22.7(4.30)          
 
 
                 





Table 12. Group differences in likelihood of depression response and remission over 12 months assessed by Generalized Estimating 
Equation (GEE) modelling 
 
§: interaction of time by group. 
 
  UC  CC  ENP  Odds Ratio P value  Odds Ratio P value  Odds Ratio P value  Interaction§ 
  N (%)  N (%)  N (%)  (95% CI)   (95% CI)   (95% CI)      
       CC vs. UC   UC vs. ENP   CC vs. ENP   X2Remission df P 
GDS                 3.37 4 0.497 
3month  39/101(38.6)  59/98(60.2)  24/51(47.1)  2.21(1.37-3.59) 0.002  0.98(0.60-1.59) 0.933  2.17(1.35-3.50) 0.001     
6month  44/99(44.4)  68/99(68.7)  34/79(43.0)              
12 month  43/90(47.8)  55/91(60.4)  30/68(44.1)              
HAMD                    
3month  32/96(33.3)  35/98(35.7)  10/49(20.4)  1.52(0.98-2.33) 0.059  1.33(0.82-2.17) 0.249  2.04(1.25-3.30) 0.004  6.21 4 0.184 
6month  26/95(27.4)  46/99(46.5)  17/76(22.4)              
12 month  32/86(37.2)  42/91(46.2)  23/65(35.4)              
BDI                    
3month  42/99(42.4)  55/98(56.1)  14/50(28.0)  1.23(0.78-1.92) 0.372  1.81(1.13-2.94) 0.015  2.23(1.36-3.63) 0.001  8.47 4 0.075 
6month  50/98(51.0)  58/99(58.6)  28/76(36.8)              
12 month  55/89(61.8)  47/91(51.7)  29/67(43.3)              
Response                    
GDS                    
3month  46/101(45.5)  58/98(59.2)  27/51(52.9)  2.21(1.32-3.70) 0.003  1.02(0.63-1.64) 0.943  2.16(1.35-3.46) 0.001  3.29 4 0.510 
6month  52/99(52.5)  69/99(69.7)  40/79(50.63)              


















Hospitalization UC VS. ENP  0.93(0.43-2.00) 0.85 1.16(0.43-3.14)  0.76 
  CC VS. ENP  0.95(0.43-2.08) 0.90 1.56(0.58-4.25)  0.38 
  CC VS. UC  1.02(0.46-2.29) 0.96 1.34(0.53-3.41)  0.53 
        
Doctor visits UC VS. ENP  0.92(0.48-1.75) 0.79 0.47(0.16-1.36)  0.16 
  CC VS. ENP  0.77(0.40-1.47) 0.43 0.53(0.18-1.52)  0.23 
  CC VS. UC  0.84(0.44-1.61) 0.60 1.12(0.43-2.95)  0.82 
        
 
 
§: multiple logistic regression was used adjusted for baseline GDS score, baseline hospitalization/doctor visits, age, gender, 
education, marital status, live arrangement, housing type, ethnic group functional disability and number of medical conditions  
 
Table 14. Patients’ satisfaction (Usual Care = 85; Collaborative Care =92) 
 
For the past 6month, how satisfied are you with the care and help you got in 
 
14.1. Understanding your problem or illness 
 






Yes No (%) No (%) No (%)  
Very Dissatisfied & Dissatisfied 0 (0) 1 (1.1) 1 (0.6) 1.00 
Neither satisfied nor dissatisfied 20 (23.5) 6 (6.5) 26 (14.7) 0.001 
Satisfied 59 (69.4) 71 (77.2) 130 (73.4) 0.243 
Very satisfied 6 (7.1) 14 (15.2) 20 (11.3) 0.087 
 
 
14.2. The advice you got about how to cope with your problem and illness 
 






Yes No (%) No (%) No (%)  
Very Dissatisfied & Dissatisfied 1 (1.2) 1 (1.1) 2 (1.1) 1.000 
Neither satisfied nor dissatisfied 16 (18.8) 7 (7.6) 23 (13) 0.027 
Satisfied 64 (75.3) 65 (70.7) 129 (72.9) 0.49 
Very satisfied 4 (4.7) 19 (20.7) 23 (13) 0.002 
 
 
14.3. The ability of your doctor in assessing and managing your emotional 
and mental health 
 






Yes No (%) No (%) No (%)  
Very Dissatisfied & Dissatisfied 9 (10.6) 2 (2.2) 11 (6.2) 0.028 
Neither satisfied nor dissatisfied 20 (23.5) 15 (16.3) 35 (19.8) 0.228 
Satisfied 51 (60) 57 (62) 108 (61) 0.79 
Very satisfied 5 (5.9) 18 (19.6) 23 (13) 0.007 
 












14.4. Having access to specialist help if you need it 
 






Yes No (%) No (%) No (%)  
Very Dissatisfied & 
Dissatisfied 
2 (2.4) 1 (1.1) 3 (1.7) 0.608 
Neither satisfied nor 
dissatisfied 
17 (20) 7 (7.6) 24 (13.6) 0.016 
Satisfied 63 (74.1) 76 (82.6) 139 (78.5) 0.169 
Very satisfied 3 (3.5) 8 (8.7) 11 (6.2) 0.216 
 
 
14.5. The amount of money you have to pay 
 






Yes No (%) No (%) No (%)  
Very Dissatisfied & Dissatisfied 0 (0) 1 (1.1) 1 (0.6) 1.00 
Neither satisfied nor dissatisfied 5 (5.9) 7 (7.6) 12 (6.8) 0.648 
Satisfied 58 (68.2) 61 (66.3) 119 (67.2) 0.785 
Very satisfied 22 (25.9) 23 (25) 45 (25.4) 0.893 
 
 
14.6. The practical support you got to continue your road to recovery 
 






Yes No (%) No (%) No (%)  
Very Dissatisfied & Dissatisfied 4 (4.7) 0 (0) 4 (2.3) 0.051 
Neither satisfied nor dissatisfied 25 (29.4) 10 (10.9) 35 (19.8) 0.002 
Satisfied 48 (56.5) 67 (72.8) 115 (65) 0.023 
Very satisfied 8 (9.4) 15 (16.3) 23 (13) 0.173 
 
 
14.7. Relieving your pain and suffering 
 






Yes No (%) No (%) No (%)  
Very Dissatisfied & Dissatisfied 5 (5.9) 1 (1.1) 6 (3.4) 0.106 
Neither satisfied nor dissatisfied 20 (23.5) 15 (16.3) 35 (19.8) 0.228 
Satisfied 56 (65.9) 59 (64.1) 115 (65) 0.807 
Very satisfied 4 (4.7) 17 (18.5) 21 (11.9) 0.005 
 





14.8. Recovering from your emotional and mental distress 
 






Yes No (%) No (%) No (%)  
Very Dissatisfied & Dissatisfied 8 (9.4) 1 (1.1) 9 (5.1) 0.015 
Neither satisfied nor dissatisfied 19 (22.4) 8 (8.7) 27 (15.3) 0.012 
Satisfied 54 (63.5) 65 (70.7) 119 (67.2) 0.313 
Very satisfied 4 (4.7) 18 (19.6) 22 (12.4) 0.003 
 
 
14.9. Returning your normal activities 
 






Yes No (%) No (%) No (%)  
Very Dissatisfied & Dissatisfied 3 (3.5) 2 (2.2) 5 (2.8) 0.672 
Neither satisfied nor dissatisfied 22 (25.9) 12 (13.0) 34 (19.2) 0.03 
Satisfied 57 (67.1) 64 (69.6) 121 (68.4) 0.72 
Very satisfied 3 (3.5) 14 (15.2) 17 (9.6) 0.01 
 
 
14.10. Overall care and help 
 






Yes No (%) No (%) No (%)  
Very Dissatisfied 1 (1.2) 1 (1.1) 2 (1.1) 1.000 
& Dissatisfied 
Neither satisfied nor dissatisfied 11 (12.9) 4 (4.3) 15 (8.5) 0.057 
Satisfied 61 (71.8) 61 (66.3) 122 (68.9) 0.433 
Very satisfied 12 (14.1) 26 (28.3) 38 (21.5) 0.022 
 
























More confident about 
diagnosing and treating 
patients with depression 
 1 (6.7) 12 (80) 2 (13.3) 
As a whole, structured, 
multi-faceted, shared care 
1 (6.7) 2 (13.3) 12 (80)  
Is applicable in primary car 
practice for managing 
patients with depression 
 1 (6.7) 12 (80) 2 (13.3) 
Produce more satisfactory 
results in managing 
patients with depression 
1 (6.7) 4 (26.7) 9 (60) 1 (6.7) 
Can be replicated under 
most conditions 
2 (13.3) 3 (20) 9 (60) 1 (6.7) 
Can be replicated under 
only certain conditions 
1 (6.7) 1 (6.7) 10 (66.7) 3 (20) 
Supports and facilitates 
continuity of care 
 1 (6.7) 12 (80) 1 (6.7) 
Is a good model for 
improving primary care of 
depressed patients 
1 (6.7) 2 (13.3) 10 (66.7) 2 (13.3) 
Will continue to participate 
in it given the right 
conditions 
1 (6.7) 2 (13.3) 10 (66.7) 2 (13.3) 
Strongly encourage MOH 
and the College of GP to 
support this primary care 
strategy 






5.1 Study I 
 
Criterion-based validity and reliability of the Geriatric Depression Screening 
Scale (GDS-15) in a large validation sample of community-living Asian older 
adults 
In our study population, the majority of participants were from social services 
users. We have limited number of participants from rehabilitation centres and 
nursing homes in our study because of their limitation in physical and mental 
ability to answer the questionnaires for interview. 
Our study differed from previous studies in several important respects. With a few 
exceptions, previous validation studies had selectively sampled elderly 
populations in medical service settings, such as GP clinics, hospital inpatient, 
nursing homes and psychiatric outpatients. We evaluated the performance of the 
GDS-15 in a large whole population validation sample of elderly persons in the 
community who were users of social services or residents of sheltered housing 
facilities. Unlike previous studies, the validation sample in our study represented a 
heterogeneous mix of different gender, age, ethnic and service settings.  
 
 We observed in our study that the sensitivity (0.96) and specificity (0.95) of the 
GDS-15 using the optimum cut off at 4/5 surpassed those in most previous studies 
(Wancata et al 2001), which reported average sensitivity of 0.805 and specificity 
of 0.750. This may be due to variations between studies in the selection 
characteristics of the screened respondents, including their cognitive status, and 
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the external criterion measure used. We did not administer the GDS to elderly 
contacts with dementia and severe cognitive impairment. Previous studies support 
the view that the GDS is not feasible for persons with marked cognitive 
impairment. The GDS has been found to have low sensitivities of only 34% 
among patients with Alzheimer’s disease (Gilley and Wilson, 1997;  Kafonek et 
al, 1986), or in a mixed group that included cognitively impaired participants, 
(47%). Another possible reason was because the GDS was administered in our 
study using face to face interviews, which probably gives higher accuracy than 
that telephone interview or self-administered questionnaire.   
 
Verification bias (or workup bias) may occur if the ‘gold standard’ SCID 
assessment of major depression was only partially available in the study 
population and the probability of ascertainment of major depression depended on 
a positive GDS screening test result and/or selected characteristics of the subjects. 
This was avoided in the present study because we performed the SCID diagnosis 
of major depression on all the subjects, irrespective of the results of the GDS 
screening test. Given this, it remain possible that the subjects who participated in 
the study might have been selected to include relatively more of those who were 
GDS-positive, but this cannot be certain, and considering their small proportion 
(7.2%), any resultant verification bias was likely to be minimal.   
 
Studies which validated the GDS-15 in clinical settings had higher reported 
prevalence of major depression (varying from 17% to 31%), and therefore 
reported high positive predictive values of 58% in inpatients or 62% in nursing 
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homes (Wancata J et al 2006). Because of the healthy selection characteristics of 
our screened population, the prevalence of major depression was only 3.4%; this 
was similar to the prevalence (3.7%) reported in an earlier national survey of the 
elderly (Ng et al, 2007). 
 
Nonetheless, the positive predictive value was high (42%). This was comparable 
to studies which validated the GDS-15 in primary care outpatients (39%). Even 
among respondents with no self-reported chronic illness(es), who had the lowest 
prevalence of major depression (0.7%), the positive predictive value was 26%. 
These data therefore lend justification to the use of the GDS in the non-clinical 
social service setting. 
 
5.2 Study II 
 




Few studies have examined differences in test performance of the GDS by 
demographic or health status groups in the same study. We observed that the GDS 
performed equally well in different age, gender and ethnic groups and among 
chronically ill and well groups. Watson et al., 2004 have reported that the 
screening accuracy of the GDS was poor in elderly above 70 years (old-old) 
healthy adults. In our study, we found no evidence that the screening accuracy of 
the GDS was poorer in older elderly above 75 years. This may be because our 
older subjects excluded most of those who were cognitively impaired. Some item 
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and test performance bias were detected that were related to older age; for 
example, older respondents were more likely to report ‘prefer staying home to 
going out’ and ‘more problems with memory than most’. These contributed 
to narrowing the differences in depressive symptoms (GDS ≥5) between the 
younger and older elderly, and incongruence with the higher prevalence of major 
depression in younger compared to older elderly, consistent with most reported 
observations. However, these discrepancies did not demonstrably affect the 
screening performance validity of the GDS in younger and older elderly.  
 
Some individual test items appeared to show gender or ethnic biases, but they did 
not appear to substantially alter the resultant pattern of depressive symptoms 
based on GDS ≥5 and major depression by gender and ethnicity. However, in 
respondents with chronic illness(es), the higher frequencies of test item 
endorsements were very consistently related to the markedly higher prevalence of 
depressive symptoms and MDD.  
 
The 15-item GDS has multiple item bias for age, gender, ethnicity and chronic 
illness in Asian older adults. With definitive identification of differential item 
functioning, some of these items in the GDS could be omitted from the scale, and 
a briefer version could be effectively used for depression screening in community-
living elderly in these social service settings. 
 
Compared to younger elderly, older elderly with the same level of depression were 
more likely to endorse the following items: ‘drop many activities and interests’, 
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‘prefer staying home’, ‘more problems with memory’, ‘feel pretty worthless’ and 
‘not full of energy’. This was consistent with known observations of age-
associated problems such as memory difficulties, diminished mobility or vitality 
(Christensen et al., 1999; Grayson et al., 2000). Previous authors have also alluded 
to the inaccuracy of using the GDS to detect clinical depression in the healthy old-
old (Watson et al., 2004). 
 
Regarding gender-specific DIF, the item bias associated with being female (‘afraid 
that something bad is going to happen’, ‘prefer staying home’, ‘more problems 
with memory’ and ‘feel situation is hopeless’) could partly be explained by 
comorbid anxiety symptoms, which are more common in females (Gorman, 2006), 
but were not explored in our study.  
 
Previous authors have pointed to possible ethnic bias in item response which is 
attributable to stronger somatic conceptualization of psychological problems 
(Harris, 2004; Kleinman, 2004; Mui et al., 2003; Niti, 2007, b). Without being 
able to demonstrate ethnicity-related DIF with clearly somatic symptoms in the 
GDS, we nevertheless observed that for the same depression level, Chinese 
respondents were more likely to endorse reports of ‘prefer staying home’, ‘think 
not wonderful to be alive’, ‘feel pretty worthless’ and ‘more problems with 
memory’. The observed item bias could be explained by ethnic differences in 
cultural beliefs, cultural values and life styles (Mui, 1996).  
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Although the GDS does not contain clearly somatic symptoms, nevertheless some 
items, such as ‘feeling worthless’ and ‘not full of energy’ were shown to have 
item bias for chronic illness, by virtue of their indirect associations, in keeping 
with other studies (Grayson et al., 2000; Niti et al., 2007, a; Yates et al., 2007).  
 
The cumulated effects of specific item-bias of age, gender, ethnicity and chronic 
illness could potentially bias the summed GDS-15 scores (test bias), independent 
of the latent level of depression. Among them, age-related DIF appeared to have 
the greatest impact on the resultant GDS scores. On the other hand, chronic illness 
has the least DIF impact because the GDS does not contain somatic questions. 
That the resultant test-level bias was only most evident for some groups but not 
for others was partly because of different threshold strengths of the cumulated 
individual item bias and because bias occurring in opposing directions for 
different items tended to cancel out or obscure the resultant test bias. 
 
We found only one other study which examined the DIF of the GDS-15 in a 
sample of 300 male Hong Kong Chinese patients with pneumoconiosis (Tang et 
al., 2005). They found no items had a significant DIF for age, education and 
cognitive impairment, using analysis of variance models. These findings based on 
a small sample size and male Chinese patients with pneumoconiosis are not 





5.3 Study III  
 
Improving Treatment Access and Acceptance for Depression in a National 
Community-Based Outreach Model (CEPIS) for the Elderly 
 
As expected, we found that sizeable numbers of seniors who were screened in the 
CEPIS outreach programme had depressive symptoms that were mostly under-
recognized and under-treated. The outreach programme had a dramatic impact in 
successfully referring a vast majority of seniors with depressive symptoms to be 
treated by trained general practitioners in the programme.  
 
Outreach service models for increasing access and use of mental health services 
by older people described in publications vary widely in their settings and 
methods of case identification, assessment, referral and treatment. Different case 
identification and referral methods used in previous outreach models include 
traditional referral (sources) model, wherein medical providers, family members, 
informal caregivers and other concerned persons identify the cases and refer them 
to mental health services. Non-traditional models include the ‘gate keeper’ model, 
whereby community service personnel who have frequent contacts with older 
persons such as meter readers and utility workers identify the cases and refer them 
to professional service centres. Outreach programmes mostly use multidisciplinary 
team management approach, but differ in the mix of providers such as nurses 
(Rabin et al, 2000; Waterreus et al, 1994), care managers (Banerjee et al, 1996), 
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physician and residential staff (Llewellyn-Jones et al., 1999) or social workers 
guided by psychiatrist (Ciechanowski et al, 2004). Outreach programme also vary 
in communication technologies, such as telephone interview and face to face 
interview, or video tape and booklets for health education and problem solving 
therapy in some programmes (IMPACT and PROSPECT). In the CEPIS 
programme, a multidisciplinary team of trained nurses, educators, counsellors, 
social workers and physician assessors, case managers, psychologists perform 
individual face-to-face interviews and health education, counselling and problem 
solving therapy and provide print reading materials for health education. 
 
Investigators have reported that the PATCH intervention program was effective 
not only because of improved case recognition through the gatekeeper outreach 
but also better treatment adherence resulting from home-based interventions by 
nurses who provided counselling, education about mental illness and positive 
health behaviour and treatment adherence. Not surprisingly, it was reported that 
seniors thus referred were more likely to have psychosocial problems such as 
living alone, marital problem and economic and social isolation (Florio et al, 
1998). The improved coverage of such outreach models is thus likely to be limited 
to severe cases most in need of services. This has been criticized and advocates 
have made a case for improving primary care and mental health services to meet 
the needs of people with moderate mental illness (Dewa et al, 2003). Other 
community-based mental health service models have sought to identify early and 
milder cases by active screening typically in primary care physicians’ clinics such 
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as in PROSPECT programme  (Bruce et al, 2004) and the IMPACT programme 
(Unutzer et al, 2002).  
 
The CEPIS programme has the unique features that case ascertainment was 
performed by trained community nurses and social workers in community settings 
where seniors spend most times. It is an inter-sectoral programme with wide 
service coverage of catchment populations of seniors who are served by a wide 
local network of social service providers. Case ascertainment was active rather 
than passive, effected through routine screening of depressive symptoms, and thus 
is more likely to cover the full range of severity of mental problems. Nurse 
educators and counsellors also provide home-based interventions through 
education and counselling on mental illness, positive health behaviour and 
treatment adherence. There is substantial evidence that routinely administered case 
finding/screening questionnaires for depression in isolation have minimal impact 
on the detection, management or outcome of depression by clinicians Gilbody et 
al, 2005), unless accompanied by more strategies in the organization and delivery 
of care, such as structured, collaborative, multi-disciplinary approach in enhancing 
care, such as case management and structured follow up. These interventional 
facets are also included in the CEPIS programme, and the results will be described 
in study IV.  
 
Data collected from the CEPIS programme provided interesting insights into the 
determinants of service use for depression among the elderly. The primary driving 
force of need-for-care was clearly borne out by the independent associations with 
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a clinically diagnosable mental disorder, fair or poor self-reported mental health, 
more depressive symptoms and perceived need for help. Under non-interventional 
conditions, the significant associations with non-need variables indicated that 
factors such as multiple medical illnesses, age, gender, education and were 
operating to predispose or enable seniors to seek treatment for depression. These 
results are similar to those reported in previous studies (Leaf et al, 1987; Lefebvre 
et al, 1998; Parslow et al, 2000). Seniors with multiple chronic physical illnesses 
were spontaneously more likely to seek treatment for their depression, most 
probably because of the close association of somatic and psychological symptoms. 
These results were consistent with those reported by previous studies (O’Neil et al, 
1984; Rhodes and Goering, 1994) 
 
These associations with treatment seeking were not found in our analysis of 
treatment-seeking under outreach interventional conditions which removed the 
barriers to healthcare, because extraneous factors no longer operated as 
predisposing or variables. Given that rates of treatment-seeking were now much 
higher overall, reverse associations were observed instead; seniors living in low-
end housing status were more likely to be treated for depression, probably for 
reasons of greater social incentives; the negative association with more chronic 
medical illnesses was explained by relatively greater numbers of seniors with 
fewer chronic illnesses being persuaded through nurses’ psychoeducation to seek 
treatment. These results strongly underscored the fact that by removing 
socioeconomic, physical, knowledge, beliefs and attitudinal barriers and 
 93
facilitating service use, a system of mental health service could provide equitable 
care to serve all in need.   
 
5.4 Study IV 
 
Randomized Controlled trial comparing collaborative shared care versus 
usual care to evaluate the effectiveness of CEPIS outreach programme 
 
All the participants from CC group completed the seven-week patient education 
protocol. Only 4 patients from CC and 3 patients from UC were referred for 
supportive counselling. Only 2 patients from CC were sent for cognitive 
behaviour therapy, however, they did not complete the therapy. Those treated with 
antidepressants in both arms completely adhered to medication. 
 
Our results showed that the percentage of drop out and loss to follow up of UC 
was 28%. The dropout rate in the CC group was considerably less (10%), but still 
indicated that despite good social support of DCM and health education of trained 
nurses, achieving complete patients’ adherence and compliance to depression 
treatment is difficult. Although psychoeducation was provided to improve 
acceptance of treatment, one third of eligible depressed elderly (36%) refused 
depression treatment. The reasons for the majority of refusals were related to 
social stigma and their belief towards the treatment and physicians. Social stigma 
about the mental illness and emotional problem is still a common problem to 
overcome in this population in Singapore. . 
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From the analysis, we found that depressed elderly provided with collaborative 
care experienced significantly greater and faster improvement in symptoms 
severity, response and remission rate and quality of life (MCS) than those who 
received usual care or eligible non-participants,. However, collaborative care did 
not have any impact on functional status or health service use. Our findings 
provided evidence that collaborative care based in the community can be 
implemented successfully to improve outcomes for patients with depression. 
 
The positive effects on depression observed in this study are consistent with other 
controlled trials conducted in Western countries in the elderly (Unützer, 2002; 
Bruce, 2004). We also found that the observed differences between the 3 groups in 
depression severity and MCS were less pronounced or insignificant at 12 months. 
This is due to the significant improvement on depression and MCS from 6 months 
to 12 months in the UC group in contrast to the remarkable improvement before 3 
months or 6 months but no change thereafter in the CC group. The probable 
reason is that the collaborative care terminated at 6 months while GPs in UC 
groups were also given feedback of the cases with depressive symptoms and 
provided physician training after 6-month intervention in CC patients was over. It 
is also, because most episodes of depression persist less than 6 months (Katon, 
1994), spontaneous remission of depression in the next half year could be another 
contributor to the narrowed differences at 12 months. Additionally, residual 
depression was found to be an important predictor of relapse of depression in 
primary care patients with depression (Lin, 1998; Simon, 2000), hence it is 
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possible that the quick recovery of CC patients in the first six months may reduce 
the risk of relapse over the second 6 months.  
 
In our study, we also demonstrated higher rate of treatment response (60.4% for 
GDS) and remission (62.6% GDS) at 12 months than those observed in IMPACT 
(25.1% for remission and 44.7% for response) (Unützer, 2002). It is likely that the 
less medical comorbidities (2.8 VS.3.2) and less ambivalence about depression 
treatment among patients and practitioners may contribute to the higher rate in this 
study. 
 
Unlike findings from IMPACT studies (Unützer J, 2002; Callahan CM, 2005), 
collaborative care did not show any favourable effects on PCS and functional 
status in this study. It is possible that we selected old patients who were 
functionally well at baseline, as evidenced by the high baseline adjusted mean 
scores of ADL and IADL (table 11), which may result in no significant change in 
functional status in our study. Conversely, patients in the IMPACT study (Unützer 
J, 2002) in both usual care control and active intervention group were more 
functionally disabled, with mean scores that were close to half of total score for 
function.  
 
Katon et al (2002) have found that collaborative care can improve depression 
outcomes without additional health care costs. Cost information is necessary in 
further study to confirm our finding and examine the cost-effectiveness of our 
 96
collaborative care intervention, given the limited evidence of cost-effectiveness in 
old patients (Katon, 2005).  
 
The diversity of community-based services sites in our study suggests broad 
potential applicability of our study findings. This is seldom addressed by many 
prior studies in primary care settings. The variety of instruments used to assess 
depression has been found to be the most important factor leading to the 
heterogeneity across studies (Gensichen, 2006). Therefore, we used 3 different 
depression assessing scales to get more robust findings. Moreover, a third control 
group (ENP) representing real world non-acceptance of treatment was also 
employed, which enhanced the external validity of our study, making the results 
much more generalizable.  
 
From feedback interviews with elderly participants, we found that the majority 
patients in both UC and CC groups were satisfied with the provision of health 
education, treatment, social support and maintenance care. However, CC 
participants were significantly more satisfied with over all care received from 
CEPIS, having access to specialist help, practical support they got to continue to 
recovery and understanding problem or illness, ability of doctor in assessing and 
managing emotional and mental health problem. From the physicians’ feedback, 
most GP agreed that CEPIS model is applicable, replicable in primary care 
practice in facilitating continuity of care, and improving their clinical competence 
in diagnosing and treating depression in the elderly. 
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Strengths and Limitations 
 
A major strength was the large sample size; hence the individual studies were 
powered to demonstrate robust relationships and statistical significance. The 
subjects in the cohort were a heterogeneous mix of elderly in terms of 
demographics and health status, in contrast to most prior studies which involved 
selected populations of vulnerable elderly.  
 
There are some limitations. The sample population was recruited from members of 
senior activities centres, day care and rehabilitation centres, and old aged homes, 
non-users of these social service portals are under-represented, and may be 
substantial in numbers. We also excluded those with dementia, functional 
disabilities, severe chronic medical illnesses (stroke, heart diseases, COPD), and 
other comorbid psychiatric disorders. These diseases and disabilities are 
commonly associated with late life depression, and evidently the validity of the 
GDS may not be generalized for these groups. Although GDS was validated with 
heterogeneous mix population, the small proportion of Malay and Indian minority 
ethics groups in the sampling population may weaken the reliability of the GDS-
15 in these small sample groups. Although based on a common Chinese text, the 
GDS was interpreted into many Chinese dialects (Mandarin, Hokkien, Teochew, 
Cantonese, Khek) by nurses, and this may introduce subtle nuances in 
interpretation and response biases. Furthermore, since the eligible participants 
who were selected to participate in the trial were free of severe chronic illnesses 
and functional ability, the results of the interventions cannot be extrapolated to 
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elderly persons who have these conditions. Because we used intent-to-treat 
approach in the analysis, loss from follow up and missing data over the study may 
possibly bias the results, although similar results were obtained from re-analyses 
with imputed data.  
 
In addition, we could not provide the physicians’ demographics and their clinical 
backgrounds to show the relationship of physicians’ characteristics and their 
satisfaction with CEPIS programme. 
 
Due to budget and resource limitations, our intervention trial period was 6 months 
and followed up our patients for 1 year. Replication of the findings is required to 
establish the sustainability of such programmes and the long-term effect of 
collaborative care. Because the eligible participants who were selected to 
participate in the trial had normal functional ability, the present study was not able 
to demonstrate beneficial effects of collaborative care in improving ADL and 
IADL functioning among those with poorer health and functioning. 
 
Because the CEPIS is an integrated multifaceted intervention, it is difficult to 
separate the individual effects of components of intervention, indeed it was not 
intended to do so. Future studies may investigate the relative importance of 





Implications of Findings 
 
The validation study of the GDS-15 provides an essential evidence base to 
recommend the use of the 15 item GDS for depression screening among the 
elderly in Singapore. The CEPIS programme outreach to the senior activity 
centres, day care centres, rehabilitation centres, old aged homes and nursing 
homes, which are located in the community, is an excellent model for community-
based programmes to screen for depression among the elderly. During the course 
of the implementing the CEPIS programme, it was apparent that it has the effect 
of stimulating much awareness of late life depression and creating the 
opportunities for providing public education to caregivers, primary care 
physicians, social workers, volunteers and staff in removing stigma and promoting 
early detection of depression. The CEPIS programme also proves to be effective 
in further educating primary care physicians about the diagnosis and treatment of 
depression. This should reduce the numbers of undertreated and undiagnosed 
cases and the number of suicide among older adult in community. The results of 
our findings provide a basis for planning future strategies for more cost effective 
multidisciplinary medical interventions for depression in the elderly.  
 
However, the extent to which these research findings and lessons from the CEPIS 
programme can be generalized to mental health services in other healthcare 
systems are limited by several assumptions. Because the project was undertaken as 
a trial project supported by research funding, financial barriers to seek treatment 
were eliminated. The results may reflect the potential benefits of such an outreach 
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service in healthcare systems where indeed free and accessible healthcare are 
available, or if presented as a special subsidized programme. They are not fully 
realizable if healthcare financing is fee-for-service. While the success of the 
outreach programme in improving status, access and acceptance of treatment is 
fully realized, its ultimate success must be evaluated in further studies of its 
effectiveness in improving mental health status and other distal outcomes. 
CEPIS could be translated to clinical practise in cost effectiveness way through 
the following procedures; 
1. Use the gate keeper model for case identification in community 
(Gate keeper model is more suitable for Asian cultures and elderly have 
confide with the persons whom they can make friends) 
2.  Provide training and education for resident/volunteer doctors at nursing home, 
old aged homes and day care centre to provide primary care level management 
of depression 
3. Employ medically trained nurses at social service centres to provide education, 
knowledge about mental health 
4. Provide education materials and workshop for volunteers, staff and elderly at 








Recommendations and Future Studies 
1.  Screening for depression is effective and feasible and should be 
performed routinely for the early detection of depression among the elderly in the 
community 
2. Psychoeducation performed by trained community nurses or other allied 
health professionals in community settings for elderly with depressive symptoms 
is also effective and feasible and is recommended to increase the usage of mental 
health care.   
3. The general practitioner (family physicians) plays a pivotal role in 
coordinating primary care treatment for depressed elderly involving 
multidisciplinary team and multi-faceted approach to depression care 
management. 
4. Further medical education and training in the primary care diagnosis and 
holistic management of depression in the elderly should be provided for primary 
care physicians. 
5. Alternative models of cost-effective multi-disciplinary and integrated care 
for depression screening and treatment should be studied. 
6. The long-term effects and impacts of CEPIS-type interventions should be 
studied. 
7. Shorter versions of the GDS may be devised but require to be validated. 
8. The utility of the GDS in elderly with severe illnesses and disabilities 
including those with dementia and multiple chronic comorbidities should be 




SUMMARY AND CONCLUSION 
 
The studies (I, II, III, IV) presented in this thesis evaluated the effectiveness of the 
CEPIS outreach model to identify depression and provide multidisciplinary team 
shared care management for community dwelling elderly. The CEPIS model was 
based on community outreach through community-based social service centres 
and screened for depression using the 15-item GDS. The GDS was validated 
against the ‘gold standard’ diagnosis of major depressive disorder based on DSM 
–IV criteria in a large heterogeneous (different age, gender, ethnicity) population 
of community dwelling elderly persons. The 15-item GDS performed equally well 
among heterogeneous sub-populations in identify depression at cut-off score of 
4/5. It showed high sensitivity (0.97) and specificity (0.95) and area under curve 
was 0.98. GDS was reliable for two weeks and consistent scoring among different 
raters. 
 
In study II, we further studied the psychometric properties of the GDS in detail, 
using differential item functioning (DIF) analysis to identify item response bias 
related to gender, age, ethnicity and chronic illness. The identification of such DIF 
has important implications for comparing the prevalence of depressive symptoms 
using GDS scores across population subgroups, cross-cultural validation of the 
GDS, and guiding the derivation of shorter versions of the scale.  
 
 103
In study III, we showed the effectiveness of psychoeducation and social support 
provided by the trained nurses in a multidisciplinary care team aimed at removing 
stigma and other psychological and physical barriers among patients and their 
caregivers and improving the acceptance of referral to primary care physicians for 
depression treatment. We found that outreach programme effectively removed the 
barriers associated with treatment seeking and increased depression treatment. The 
acceptance of treatment referral was increased to 73% from 10%. By eliminating 
socioeconomic, physical, and cognitive barriers, equitable care provided in an 
outreach programme increased primary care treatment for depression. 
 
We conducted a double-blind randomized controlled trial (Study IV) to compare 
collaborative care and usual care approach to depression treatment in primary 
care. After 12 months, depressive symptoms were significantly reduced, and 
health related quality of life significantly improved more in collaborative care 
group than in usual care group. Collaborative care resulted in greater and faster 
improvement of depressive symptoms and quality of life than conventional or 
usual care. According to overall population of Singapore, the majority of our study 
population was Chinese ethnicity. However, our results were able to demonstrate 
that CEPIS model was effective and feasible in a heterogeneous population of 
community-living elderly population in Singapore. The CEPIS model also 
demonstrates that it was feasible to enlist primary care physicians to be trained in 
managing depression among elderly patients. Positive feedbacks from patients and 
primary care physicians indicate wide acceptance for the CEPIS model of care. 
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Translation of results findings into actionable public health policy, programs 
and practices 
a. From the data analysis and results, Comment on how the findings 
could be translated into actionable public health policy, programs and 
practices. 
Late life depression is a major public health problem world-wide and the 
partnerships of providers, patients, and policy makers play an important role in 
overcoming the challenges related to funding, training, and implementing 
treatments for this condition. 
From the results of our intervention study based on Singapore community 
dwelling elderly, there are three main issues in translating the intervention study to 
real world policy, programmes and practices. They are financial support, social 
support and, public knowledge and attitude (stigma) for mental health. In the 
intervention study, the expenses for medication and physicians visits for the 
depressed elderly were fully subsidized and they received psycho-education and 
social support by trained research nurses free of charge. Therefore the acceptance 
rate of treatment for depression and compliance to visit to physicians and 
medications is expectedly higher. This may not match real world situations in 
healthcare systems which are not fully or largely subsidized through universal 
healthcare insurance or public funding. However, they are consonant with 
healthcare systems which aim to provide universal healthcare access. In a hybrid 
system like Singapore’s, nevertheless, special provisions can be made for 
dedicated programmes of this sort if it can be adequately justified to be cost-
effective. In Singapore, elderly are already subsided for the medical expenses at 
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polyclinics and fares on public transportation. Most elderly prefer to consult their 
neighborhood primary care giver (general practitioners) for their illnesses and 
especially for their mental illness. Therefore, the possibilities for translating the 
findings from this interventional study to real world policies, programs and 
practices include: 
Public health policies 
1. Fully subsidized medical scheme for needy and at risk elderly particularly 
those lacking financial support, who needed to seek treatment from primary care 
givers in their neighborhood 
2. Health insurance policy to cover mental health illness 
Public health programmes 
1. Public awareness programmes/ campaign (health education work shop, 
talk ) for mental health illnesses (e.g depression, dementia) to remove stigma 
2. Training of screening for mental health illnesses at community based 
social service centers 
3. Recruitment and training of social workers to deal with social and 
financial problems of elderly 
Public health practices 
1. Provide training and workshop for primary caregivers for assessment and 
management of mental health illnesses 
2. Provide training of psycho-education and social counseling for elderly 
volunteers, social workers and staff of social service centers. 
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b. Estimate what would be the likely socio-economic effect size of the 
proposed CEPIS program? 
The policy decision-making process for implementing the CEPIS-type programme 
should of course consider the socio-economic benefits from the programme versus 
the costs of implementing the programme. Clearly, the benefits should be seen to 
outweigh the costs from economic analysis of the direct and direct costs of 
treating depression in the elderly currently in the absence of such a programme 
versus the direct and indirect costs if the programme were implemented with the 
additional resource inputs.   
The benefits from the intervention study derived from the early identification of 
depressed cases in the community and increased treatment seeking from mental 
health services include better quality of life for the depressed elderly and reduced 
caregivers burden. Without the intervention programme, undetected and untreated 
cases of depression translate to greater morbidity and increased healthcare 
expenditure, and decreased quality of life and greater social and financial burden 
to families. An cost-benefit or cost-effectiveness analysis of a CEPIS programme 
is difficult, and is beyond the scope of this thesis, but may be attempted in future 
with real world data if available. These studies should take into account not only 
the total direct costs of treating depression in terms of healthcare resources used, 
but also the indirect social and economic costs mostly borne by caregivers and 
society in terms of employment days lost, transportation costs, etc from providing 
care and assistance. For example, the direct costs included in a CEPIS programme 
will include incremental cost for employment and training of additional research 
nurses, psychologists, counselors and neighborhood primary caregivers (GP), and 
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the cost of subsidized medications for depressed elderly. This may be offsetted 
against the savings from reduced healthcare costs from translating a 50% 
reduction in depressive symptoms and remission rates under the intervention 
programme associated to quantified depression-free days. This may be evaluated 
vis-à-vis the direct and indirect costs from greater healthcare resource utilization 
and caregiver and societal burden from more untreated or poorly treated 
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Appendix 5. CONFIDENTIAL 
 
 ‘Community-based Early Psychiatric Interventional Strategy’ (CEPIS) Study 





Subject’s initials: _________         Subject No:  
                                    F  M  L 
Today’s date: ______/______/_________      Language:   _____________________ 
           Mon     day       year 
 
Reasons for encounter: 
1    
    
 
2     
3     
 
SD2. Age 
   
SD3. Gender SD4.  Ethnicity 
 1.Chinese  3. Indian 
 2.Malay  4. Others 
 1. Male 
 2. Female  
                  
 
SD5.  Educational Level (Check One) SD6.   Marital Status (Check One) 
 1. No formal education  1. Never married (single) 
 2. Primary education 1-6  2. Married (or de facto) 
 3. Secondary education 1-4 / Vocational /ITE  3. Divorced or separated 
 
4. Post-secondary College (JC 1-2), Polytechnic, 
Pre-Univ (Pre-U 1-2)  
4. Widowed 
 5. Tertiary (University)   
 
SD7.       Living Arrangement (Check One) SD8 Housing Type 
 1) Lives alone  1. 1 room rental HDB flat 
 2) Lives with spouse/partner only  2. 2 room HDB 
3) Lives with spouse and children only   3. 3-4 room HDB 
 4) Extended family  4. 5 room, Exec HDB 
 5) Lives with friend(s) only  5. Condo and private apartment 
 6) Nursing Home  6. Landed house 




15 item Geriatric Depression Scale 












Are you basically satisfied with your life? 
你基本上满意自己的生活吗？ 
Adakah anda pada asasnya berpuas hati dengan kehidupan anda? 
    
2 
Have you dropped many of your activities and interests? 
你是不是已经放弃了很多以前的活动和嗜好？ 
Adakah anda telah meninggalkan banyak kegiatan dan minat anda? 
    
3 
Do you feel that your life is empty? 
你是不是觉得生活没意思？ 
Adakah anda berasa hidup anda kekosongan? 
    
4 
Do you often get bored? 
你是不是常常感到烦闷？ 
Adakah anda sering berasa bosan? 
    
5 
Are you in good spirits most of the time? 
你是不是很多时候感到心情愉快呢？ 
Adakah anda bersemangat dalam kebanyakan masa? 
    
6 
Are you afraid that something bad is going to happen to you? 
你是不是害怕将会有不好的事情发生在你身上呢？ 
Adakah anda bimbang sesuatu yang buruk akan terjadi pada anda? 
    
7 
Do you feel happy most of the time? 
你是不是很多时候感到开心？ 
Adakah anda merasa gembira dalam kebanyakan masa? 
    
8 
Do you often feel helpless? 
你是不是常常感到没办法？ 
Adakah anda sering berasa tidak berdaya? 
    
9 
Do you prefer to stay at home, rather than going out and doing new things? 
你是不是甘愿留在家里，而不爱出外做些新的事情？ 
Adakah anda lebih suka duduk di rumah daripada keluar dan melakukan 
sesuatu perkara/hal yang baru? 
    
10 
Do you feel you have more problems with memory than most? 
你是不是觉得你的记忆力比多数的人来得差？ 
Adakah anda berasa bahawa anda mempunyai lebih banyak masalah daya 
ingatan daripada orang lain? 
    
11 
Do you think it is wonderful to be alive? 
你认为现在活着是一件好事吗？ 
Adakah anda fikir alangkah baiknya untuk hidup sekarang? 
    
12 
Do you feel pretty worthless the way you are now? 
你是不是觉得自己现在没有用？ 
Adakah anda merasa keadaan anda sekarang kurang berguna? 







Do you feel full of energy? 
你是不是感到很有精神？ 
Adakah anda berasa penuh bertenaga? 
    
14 
Do you feel that your situation is hopeless? 
你是不是觉得自己的处境没有希望？ 
Adakah anda berasa keadaan anda tidak ada harapan? 
    
15 
Do you think that most people are better off than you are? 
你觉得大多数人的情况比你好吗？ 
Adakah anda fikir bahawa kebanyakan orang adalah lebih baik daripada anda? 
    








Source of Medical History    
(Choose one)  
(a) 
Do you have any of 
the following 









In the past 1 year, how 
many times (at least) 
have you 
(d) 






 1) Medical Report      
2) Self Report             



















  (1) (2)    (1) (2) 
MP1 Coronary artery disease        
MP2 Heart failure        
MP3 High blood pressure        
MP4 High cholesterols/lipids        
MP5 Diabetes        
MP6 Stroke        
MP7 Cataracts/ major eye 
problems        
MP8 Arthritis        
MP9 Hip fracture        
MP10 Cancer        
MP11 Kidney failure        
MP12 Urinary        
MP13 Asthma  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MP14 Chronic lung disease        
Mental health disorder, 
e.g. anxiety, depression, 
etc 
MP15 
       
Any other problems  MP16 










































PATIENT INFORMATION SHEET 
(GP Group Intervention ) Version No: 0002  Date (12/01/2006)  
 
I.  Study Information 
Protocol Title: 
Randomized Controlled Trial of a Community-based Early Psychiatric Intervention 
strategy (CEPIS) to Screen and Manage Depression in the Elderly 
 
Principal Investigator & Contact Details: 
 
Principal Investigators: 
A/P Ng Tze Pin 
A/P Calvin Fones 
Dr. Jin Aizhen 
A/P Ko Soo Meng 
Dr Chiam Peak Chiang 
 
Contact: 
Dr Jin Aizhen, Co-investigator, Project Coordinator (Mobile: 94315162) 
Ms Pang Minyi, Project Administrator ( 67724518 ) 
 
Gerontological Research Programme 
National University of Singapore, 
Department of Psychological Medicine 
National University Hospital, 5 Lower Kent Ridge Road, 
Singapore 119074 
Fax: 65-67772191, Tel: 65-67724514 
 
Study Sponsor: 
BMRC-NMRC Research Grant (Ref: 03nov056) 
 
II.  Purpose of the Research Study 
 
1. You are invited to participate in a research study.  It is important to us that you first take 
time to read through and understand this information sheet.  Nevertheless, before you take 
part in this research study, the study will be explained to you and you will be given the chance 
to ask questions. After you are properly satisfied that you understand this study, and that you 
wish to take part in the study, you must sign this informed consent form.  You will be given a 
copy of this consent form to take home with you. 
2.You are invited because you are aged 60 or above, and your screening questionnaire  
indicate the presence of some depressive symptoms, for which it would be advisable for you 
to get the attention of a family doctor. 
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3.This study is carried out to find out whether re-organizing the usual ways which your doctor 
in general practice identify and manage patients with emotional and mental health problems 
can better help and improve care for patients.  
 
This study will recruit about 240 subjects from the (1) the Gerontological Research 
Programme/ Singapore Longitudinal Aging Study Centre in Southeast CDC and (2) Singapore 
Action Group of Elders (SAGE) Elderly Suicide Prevention Workgroup network of participating 
social service centres (SAGE Counselling Centre, Ministry of Community Development Family 
Service Centres, NTUC Community Eldercare Service, Tsao Foundation, Lions befrienders, etc)  
over a period of 2 years. These subjects will be referred by the investigators to a panel of 
doctors in general practice for further attention of their mental health problems. The duration 
of individual subject’s participation in this research is six months. 
 
 
III. What procedures will be followed in this study  
 
1. If you take part in this study, you will be randomized to receive attention by either (1) a GP 
who is participating in a structured, integrated, shared care programme of early intervention 
for depression or (2) a GP who is not participating in this programme, and will be assessing 
and managing patients in the usual way . This doctor may or may not be your neighbourhood 
doctor that you usually consult. Randomization means assigning you to one of these two 
groups by chance, like tossing a coin or rolling dice. 
 
2. You will be assessed by the research staff for eligibility to participate in the study first. To 
be eligible, you should not have: 
1. Serious psychiatric illness, or serious suicidal risk.  
2. Alzheimer’s disease or dementia 
3. Severe functional restrictions on activities of daily living. 
4. Serious mental disability after stroke.  
5. Have a psychiatric consultation or admission to hospital in the past 3 months 
6. Other difficult or serious conditions or states which require more specialized attention. 
 
If you take part in this care intervention, you will be assessed thrice by the investigators, once 
before referral to GP, once three months later and six months later after referral to GP. 
Detailed questionnaire interviews and other assessments will last one hour. You will be 
referred to a participating GP assigned by the research team. The GP will require you to visit 
him at intervals stipulated by him/her, provide advice and counsel, and if deemed necessary, 
recommend investigations, medications, or referral to counseling or psychiatric specialist 
service, and care support by a nurse/ case manager.  
 
3.If you agree to take part in this study, the following will happen to you: 
Visit 1:  Eligibility assessment: questionnaire interview, blood tests (haematological, lipid, 
liver, renal, endocrine panels, B12, folate), ECG and CXR, for assessment of co-existing 
medical conditions, and exclusion of vascular dementia, Alzheimer's disease, and post-stroke 
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dementia. In total, 20 ml of blood will be taken if necessary. 
Visit 2: (Baseline): Questionnaire interview.  Refer to assigned GP  
Visit 3: (3 months): Questionnaire interview.  
Final Visit: (6 months): Questionnaire interview. 
 
Follow-up 
When your participation in the study ends, you will no longer remain under the care of the GP 
who was assigned to you, unless you choose to do so; you will no longer have access to free 
consultations, medications, or counseling or specialist service, unless special additional 
arrangements are made by the Principal Investigator. 
 
IV.  Your Responsibilities in This Study 
If you agree to participate in this study, you should follow the advice given to you by the 
research team.  You should be prepared to visit the GP assigned to you at intervals set by 
him/her, receive advice and treatment as recommended by him/her, and to visit or be visited 
by our research nurses for interviews that are outlined above. 
 
V.  What Is Not Standard Care or Experimental in This Study 
The study is being conducted because the interventional programme is not yet proven to be a 
standard programme of care in subjects with depressive symptoms. We hope that your 
participation will help us to determine whether the interventional programme is equal or 
superior to existing pattern of care.  
Blinding (one or more parties unaware of the treatment assignment), and randomization 
(assigning to GP by chance) are only done for research studies. . 
Although nurse/case manager support, referral to counseling and specialist service may be 
part of standard medical care, in this study these services are only being performed for the 
purposes of the research, and are not part of your routine care. 
 
VI.  Possible Risks and Side Effects 
 
Obtaining blood can cause pain, bleeding, bruising, or swelling at the site of the needle stick. 
Fainting sometimes occurs and infection rarely occurs. 
The interventional programme only evaluates management approach in patient care. As such, 
there is no physical or mental risk at all directly connected to your participation in this 
programme of care.  
No untested or experimental drugs are used in this research.  
The GP who attends to your depressive symptoms has full personal autonomy in deciding on 
further assessment and treatment that are in your best interest. Your attending GP and 
specialist bear direct professional responsibility for their patient care, and drugs are prescribed 
by them at their sole discretion.   
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Although only standard approved drugs are prescribed, allergic reactions can occur. Common 
symptoms may include: rash, itching etc. Rarely, a severe and possibly life-threatening 
allergic reaction can occur. Symptoms of a severe reaction include: swelling of the face, 
difficulty breathing, a sudden drop in blood pressure that may cause dizziness. If you have 
any of these symptoms, call your doctor at once.  
If you experience any new symptoms, you should contact your GP or specialist, as soon as 
possible. 
 




VIII.  Alternatives to Participation 
If you choose not to take part in this study, you will receive standard care for your condition. 
According to current practice, this would be informing you of the results of your screening 
test and advising you to seek further advice from a GP or counselor of your choice.   
 
IX. Possible Benefits from Participating in the Study 
 
There is no assurance you will benefit from participation in this study. However, your 
participation in this study may add to the medical knowledge about the use of this 
management approach to patient care.  
 
X. Costs & Payments if Participating in the Study 
 
If you take part in this study, the following will be performed at no charge to you:  
GP consulting fees, blood and other tests, and referred counseling and specialist services, and 
medications for emotional and mental health problems that are directly connected to this 
study.    
 
If you take part in this study, you will have to pay for the following:  
Fees and expenses charged by the GP for other conditions that you have, which are not related 
to the study. 
 
You will be reimbursed for your time, inconvenience and transportation costs as follows:  
• If you complete the study, you will be paid $60.  
• If you do not complete the study for any reason, you will be paid $10  for each visit to 
the research centre (not GP, counselor or specialist) you complete. 
 
XI. Voluntary Participation 
Your participation in this study is voluntary. You may stop participating in this study at any 
time. Your decision not to take part in this study or to stop your participation will not affect 
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your medical care or any benefits to which you are entitled. If you decide to stop taking part 
in this study, you should tell the Investigator (Dr Jin Aizhen), by contacting the study 
coordinator (Ms Pang Minyi).  
Your doctor, the Investigator and/or the Sponsor of this study may stop your participation in 
the study at any time if they decide that it is in your best interests. They may also do this if 
you do not follow instructions required to complete the study adequately. If you have other 
medical problems or side effects, the doctor and/or nurse will decide if you may continue in 
the research study.  
In the event of any new information becoming available that may be relevant to your 
willingness to continue in this study, you or your legal representative will be informed in a 
timely manner by the Principal Investigator or his/her representative. 
 
XII. Compensation for Injury 
Payment for management of the normally expected consequences of your treatment will not 
be provided by the National University of Singapore.  By signing this consent form, you will 
not waive any of your legal rights or release the parties involved in this study from liability 
for negligence. 
 
XIII. Who To Contact if You Have Questions 
If you have questions about this research study, you may contact the Principal Investigator, 
(Dr Jin Aizhen, Mobile: 94315162 ) 
In case of any injuries during the course of this study, you may contact the Principal 
Investigator, (Dr Jin Aizhen, Mobile: 94315162 ) 
If you want an independent opinion of your rights as a research subject you may contact the 
NHG Domain-Specific Research Board Secretariat (Attn: Sujatha Sridhar) at 6471-3266. 
 
XIV. Confidentiality of Study and Medical Records 
Information collected for this study will be kept confidential. Your records, to the extent of 
the applicable laws and regulations, will not be made publicly available.  
However, the Regulatory Agencies and NHG Domain-Specific Review Board and Ministry of 
Health will be granted direct access to your original medical records to check study 
procedures and data, without making any of your information public. By signing the Informed 
Consent Form attached, you or your legal representative is authorizing such access to your 
study and medical records. 
Data collected and entered into the Case Report Forms are the property of National University 








Version: 0002  Date: 12/01/2006 
Protocol Title: 
Randomized Controlled Trial of a Community-based Early Psychiatric Intervention 
strategy (CEPIS) to Screen and Manage Depression in the Elderly 
Principal Investigator & Contact Details: 
Dr Jin Aizhen, Co-investigator, Project Coordinator (Mobile: 94315162) 
Ms Pang Minyi Project Administrator ( 67724518 ) 
Gerontological Research Programme 
National University of Singapore, 
Department of Psychological Medicine 
National University Hospital, 5 Lower Kent Ridge Road, 
Singapore 119074 
Fax: 65-67772191, Tel: 65-67724514 
 
I voluntarily consent to take part in this research study. 
 
I have fully discussed and understood the purpose and procedures of this study.  
 
This study has been explained to me in 
_________________________________(language)  
on ______________ (date) by _______________________________(name of translator).  
I have been given enough time to ask any questions that I have about the study, and all 
my questions have been answered to the best of my doctor’s ability.  
 
_______________________   _________________   
Name of Patient Signature Date 
 
_______________________   _________________   




I, the undersigned, certify to the best of my knowledge that the patient signing this 
informed consent form had the study fully explained and clearly understands the nature, 





_______________________   _________________   




Beck Depression Inventory         .                                                                 Total  
 
Choose the best answer for how you felt this past week 
 
 
Q1.  0. I do not feel sad. 
  1. I feel sad. 
  2. I am sad all the time and I can’t snap out of it. 
  3. I am so sad and unhappy that I can’t stand it. 
 
Q2.  0. I am not particularly discouraged about the future. 
  1. I feel discouraged about the future. 
  2. I feel I have nothing to look forward to. 
  3. I feel the future is hopeless and that things cannot improve 
 
Q3.  0. I do not feel like a failure. 
  1. I feel I have failed more than the average person. 
  2. As I look back on my life, all I can see is a lot of failures. 
  3. I feel I am a complete failure as a person. 
 
Q4.  0. I get as much satisfaction out of things as I used to. 
  1. I don’t enjoy things the way I used to. 
  2. I don’t get real satisfaction out of anything anymore. 
  3. I am dissatisfied or bored with everything. 
 
Q5.  0. I don’t feel particularly guilty. 
  1. I feel guilty a good part of the time. 
  2. I feel guilty most of the time. 
  3. I feel guilty all of the time 
 
Q6.  0. I don’t feel I am being punished. 
  1. I feel I may be punished. 
  2. I expect to be punished. 
  3. I feel I am being punished. 
 
Q7.  0. I don’t feel disappointed in myself. 
  1. I am disappointed in myself. 
  2. I am disgusted with myself. 
  3. I hate myself. 
 
Q8.  0. I don’t feel I am any worse than anybody else. 
  1. I am critical of myself for my weakness or mistakes. 
  2. I blame myself all the time for my faults. 
  3. I blame myself for everything bad that happens. 
 
Q9.  0. I don’t have any thoughts of killing myself. 
  1. I have thoughts of killing myself, but I would not carry them out. 
  2. I would like to kill myself. 
  3. I would kill myself if I had the chance. 
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Q10. 0. I don’t cry any more than usual. 
  1. I cry more now than I used to. 
  2. I cry all the time now. 
  3. I used to be able to cry, but now I can’t cry even though I want to. 
 
 
Q11. 0. I am no more irritated by things than I ever was. 
  1. I am slightly more irritated now than usual. 
  2. I am quite annoyed or irritated a good deal of the time. 
  3. I feel irritated all the time. 
 
Q12. 0. I have not lost interest in other people. 
  1. I am less interested in other people than I used to be. 
  2. I have lost most of my interest in other people. 
  3. I have lost all of my interest in other people. 
 
Q13. 0. I make decisions about as well as I ever could. 
  1. I put off making decisions more than I used to. 
  2. I have greater difficulty in making decisions more than I used to. 
  3. I can’t make decision at all anymore. 
 
Q14. 0. I don’t feel that I look worse than I used to. 
  1. I am worried that I am looking old or unattractive. 
  2. I feel that there are permanent changes in my appearance that make me look 
unattractive. 
  3. I believe that I look ugly. 
 
Q15. 0. I can work about as well as before. 
  1. It takes an extra effort to get started at doing something. 
  2. I have to push myself very hard to do anything. 
  3. I can’t do any work at all. 
 
Q16. 0. I can sleep as well as usual. 
  1. I don’t sleep as well as I used to. 
  2. I wake up 1-2 hours earlier than usual and find it hard to get back to sleep. 
  3. I wake up several hours earlier than I used to and cannot get back to sleep. 
 
Q17. 0. I don’t get more tired than usual. 
  1. I get tired more easily than I used to. 
  2. I get tired from doing almost anything. 
  3. I am too tired to do anything. 
 
Q18. 0. My appetite is no worse than usual. 
  1. My appetite is not as good as it used to be. 
  2. My appetite is much worse now. 
  3. I have no appetite at all anymore. 
 
Q19. 0. I haven’t lost much weight, if any, lately. 
  1. I have lost more than five pounds. 
  2. I have lost more than ten pounds. 
  3. I have lost more than fifteen pounds. 
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Q20. 0. I am no more worried about my health than usual. 
  1. I am worried about physical problems such as aches and pains, or upset stomach 
or  
   constipation.     
  2. I am very worried about physical problems and it’s hard to think of much else. 
  3. I am so worried about my physical problems that I cannot think about 
anythingelse. 
 
Q21. 0. I have not noticed any recent change in my interest in sex. 
  1. I am less interested in sex than I used to be. 
  2. I have almost no interest in sex. 







































Hamilton Depression Rating Scale (SIGH-D) 
For each item, write the correct number on the line next to the item. (Only one response per item)  
H1  DEPRESSED MOOD (Sadness, hopeless, helpless, worthless) 
  0 = Absent 
  1 = Indicated only on questioning 
  2 = Spontaneously reported verbally 
  3 = Communicated non-verbally, ie.facial expression, posture, voice, tendency to weep 
  4 = VERTUALLLY ONLY: this in spontaneous verbal and non-verbal communication 
   
H2  FEELINGS OF GUILT 
  0 = Absent 
  1 = Self reproach, feels he / she has let people down 
  2 = Ideas of guilt or rumination over past errors or sinful deeds 
  3 = Present illness is a punishment. Delusions of guilt 
  4 = Hears accusatory or denunciatory voices and/or experiences threatening visual 
   Hallucinations.  
   
H3  SUICIDE 
  0 = Absent 
  1 = Feels life is not worth living 
  2 = Wishes he were dead or any thoughts of possible death to self 
  3 = Suicidal ideas or gestures 
  4 = Attempts at suicide  
   
H4  INSOMNIA EARLY 
  0 = No difficulty falling asleep 
  1 = Complains of occasional difficulty falling asleep-i.e., more than ½ hour 
  2 = Complains of nightly difficulty falling asleep  
    
H5  INSOMNIA MIDDLE 
  0 = No difficulty 
  1 = Patient complains of being restless and disturbed  
  2 = Waking during the night-any getting out of bed rates 2 (except avoiding  bladder)  
    
H6  INSOMNIA LATE 
  0 = No difficulty 
  1 = Waking in early hours of the morning but goes back to sleep 
  2 = Unable to fall asleep again if gets out of bed  
   
H7  WORK AND ACTIVITIES 
  0 = No difficulty 
  1 = Thoughts and feeling of incapacity, fatigue or weakness related to activities, work or 
   Hobbies 
  2 = Lost of interest in activity; hobbies or work-by direct report of the patient, or indirect 
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   in listlessness, indecision and vacillation (feels he has to push self to work or activities) 
  3 = Decrease in actual time spent in activities or decrease in productivity. In hospital, patient 
   Spends less than 3 hours/day in activities (hospital job or hobbies) exclusive of ward chores 
  4 = Stop working because of present illness. In hospital, no activities except ward chores, or  
             Fails to perform ward chores unassisted 
   
H8  RETARDATION (Slowness of thought and speech; impaired ability to concentrate; decreased 
  motor activity) 
  0 = Normal speech and thought 
  1 = Slight retardation at interview 
  2 = Obvious retardation at interview 
  3 = Interview difficult 
  4 = Complete stupor 
    
H9  AGITATION 
  0 = None 
  1 = Fidgetiness 
  2 = Playing with hands, hair, etc. 
  3 = Moving about, can't sit still 
  4 = Hand wringing, nail biting, hair-pulling, biting of lips 
    
H10  ANXIETY (PSYCHIC) 
  0 = No difficulty 
  1 = Subjective tension and irritability 
  2 = Worrying about minor matters 
  3 = Apprehensive attitude apparent in face or speech 
  4 = Fears expressed without questioning 




ANXIETY SOMATIC: Concomitants of anxiety, such as  
GI: dry mouth, gas, indigestion, diarrhea, cramps, belching 
C-V: HEART PALPITATIONS, HEADACHES 
Resp: hyperventilating, sighing 
Having to urine frequently 
Swearing 
  0 = Absent 
  1 = Doubtful or trivial: minor symptoms elicited by direct questioning 
  2 = Mild: spontaneously describes symptoms, which are not marked by incapacitating 
  3 = Moderate: greater number and frequency of symptoms than (2). Accompanied by more 
   Subjective distress and serve to impair more normal functioning 
  4 = Severe: symptoms are numerous, persistent and incapacitating much of the time, or  
   Panic attacks almost daily 
    
H12  SOMATIC SYMPTOMS (GASTROINTESTINAL) 
  0 = None 
  1 = Loss of appetite but eating without encouragement 
  2 = Difficulty eating without urging.  
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H13  SOMATIC SYMPTOMS (GENERAL) 
  0 = None 
  1 = Heaviness in limbs, back or head. Backaches, headache, muscle aches.  
   Loss of energy and fatigability 
  2 = Any clear-cut symptom rates 2  
    
H14  GENITAL SYMPTOMS (such as: loss of libido; menstrual disturbances) 
  0 = Absent: no loss of libido; impaired sexual performance 
  1 = Mild or infrequent: loss of libido; impaired sexual performance 
  2 = Obvious and severe: complete loss of sexual appetite 
    
H15  HYPOCHONDRIASIS 
  0 = Not present 
  1 = Self-absorption (bodily) 
  2 = Preoccupation with health 
  3 = Frequent complaints, requests for help, etc 
  4 = Hypochondriacal delusions  
    
H16  LOSS OF WEIGHT (since onset of illness or last visit): 
  0 = No weight loss or weight loss NOT caused by present illness 
  1 = Weight loss probably caused by present illness. Loss of less than one pound 
  2 = Definite weight loss caused by present illness. Loss of one pound or more 
H17  INSIGHT 
  0 = Acknowledges being depressed and ill OR not currently depressed 
  1 = Acknowledges illness but attributes cause to bad food, climate, overwork,  
 virus, need for rest, etc.   
  2 = Denies being ill at all  
    



















SF-12  for Quality of Life   
 
SF 1.  In general, would you say your health is:            (Tick one) 
 Excellent ............................................................................  (1) 
 Very good .........................................................................  (2) 
 Good ..................................................................................  (3) 
 Fair .....................................................................................  (4) 
 Poor ...................................................................................  (5) 
 
The following questions are about activities you might do during a typical day. Does your 
health now limit you in these activities ? If so, how much ? 










  (1) (2) (3) 
SF 2 
Moderate activities, such as moving a table, 
pushing a vacuum cleaner, bowling, or 
playing golf 
 
   
SF 3 Climbing several flights of stairs 
 
   
 
 
During the past four weeks, have you had any of the following problems with your work or 
other regular daily activities as a result of your physical health ?    
   
  Yes (1) No (2) 
Accomplished less than you would like 
SF 4    
Were limited in the kind of work or other 
activities  SF 5   
 
During the past four weeks, have you had any of the following problems with your work or 
other daily activities as a result of any emotional problems (such as feeling depressed or 
anxious)?                                




SF 6 Accomplished less than you would like   
SF 7 Didn’t do work or other activities as carefully as usual   
SF Add Cut down on the amount of time you spent on work or









SF 8. During the past four weeks, how much did pain interfere with your normal work 
(including both work outside the home and housework) ? 
 Not at all ...........................................................................   (1)  
 A little bit..........................................................................   (2) 
 Moderately ......................................................................   (3) 
 Quite a bit .........................................................................   (4) 
 Extremely ..........................................................................   (5) 
 
 
These questions are about how you feel and how things have been with you during the past 
four weeks. For each question, please give the one answer that comes closest to the way you 
have been feeling. How much of the time during the past four weeks – 
       
















  (1) (2) (3) (4) (5) (6) 
 
Have you felt calm and 
peaceful ? 
SF 9 
      
 
Did you have lots of energy ? SF 10       
 
Have you felt downhearted and 
low ? 
SF 11 
      
 
 
SF-12. During the past four weeks, how much of the time has your physical health or 
emotional problems interfered with your social activities (like visiting with friends, relatives, 
etc ?) 
     
 All of the time ...................................................................  (1) 
 Most of the time ...............................................................  (2) 
 Some of the time .............................................................  (3) 
 A little of the time ...........................................................  (4) 
 None of the time .............................................................  (5) 
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